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ABSTRACT 
Synthetic biological circuits are the foundation for the ultimate goals of controlling 
cells and building artificial cells from the ground up. To get closer to these goals in a 
more efficient way, we utilize a cell-free transcription-translation system to help 
perfect biological circuits for the simplicity, freedom, and convenience that the 
system offers. In this thesis, we demonstrate three distinct aspects of biological 
circuits in a cell-free transcription-translation system: circuit dynamics, 
phosphorylation, and membrane proteins. We start with a simple feedforward circuit, 
which shows dynamic responses to the input. We first prototype the feedforward 
circuit in the cell-free system with the aid of mathematical modeling. Then, based on 
the knowledge learned from prototyping, we successfully implement the circuit in 
cells. Not only do we show that a circuit with dynamics can be prototyped in the cell-
free system, but we also test a more complicated circuit involving a phosphorylation 
cycle. The phosphorylation-based insulator circuit is prototyped and then a model 
created for the circuit is shown to be identifiable in the cell-free system. To further 
expand the capability of the cell-free system, we demonstrate that biologically active 
membrane proteins can be generated in the cell-free system with engineering, 
suggesting that even biological circuits requiring membrane proteins can be 
prototyped in the system. These results help advance our knowledge of both 
biological circuits and the cell-free transcription-translation system, and bring us one 
step closer to our ultimate goals of implementing control theory in synthetic biology. 
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Introduction 1 
INTRODUCTION 
The relatively recent rise of synthetic biology mainly begins with the publications of 
a synthetic repressilator [4] and a genetic toggle switch [5]. As more efficient 
biotechnology tools are being developed [6-10], the young field has advanced 
significantly [11, 12]. In this thesis, we focus on one important aspect of the synthetic 
biology – synthetic biological circuits. Biological circuits, the basis of synthetic 
biology, can be used to program cells to perform distinct functions, such as 
biosensors [13, 14], metabolites synthesis [15-17], and so on. However, the lack of 
modularity and robustness of some biological circuits often limits their  
applications [18, 19]. In order to deepen our understanding of biological circuits in a 
more efficient fashion, we utilize a cell-free transcriptional-translation system (TX-
TL) to prototype, characterize, and implement the biocircuits [20, 21]. 
In Chapter 1, we demonstrate that a simple novel synthetic biological circuit, 
exhibiting dynamic response, can be prototyped in the TX-TL system with the aid of 
mathematical modeling. We further show that the characterized feedforward loop 
circuit can be implemented in cells with minimum optimizations. This chapter, 
together with previous studies [22-24], suggests that the TX-TL system is an easy-
to-use, convenient, and efficient approach to prototype biocircuits. 
In Chapter 2, built on our understanding from chapter 1, we prototype and 
characterize a more complicated biocircuit – a phosphorylation-based insulator – in 
the TX-TL system. We demonstrate that non-transcriptional regulations, such as a 
phosphorylation cycle, can be prototyped in the TX-TL system as well. Not without 
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its limitations, but TX-TL, as shown in this chapter, provides a useful system for not 
only circuit prototyping but also system identification. With the additional degrees 
of freedom provided by the TX-TL system (comparing to cell-based systems), we 
can identify the parameters of our mathematical model for this biocircuit using actual 
experimental data. 
Finally, in Chapter 3, we discuss the possibility of expanding the capabilities of 
the TX-TL system. We demonstrate that biologically active membrane proteins can 
be expressed in the membrane-less TX-TL system with further engineering. 
Membrane proteins, which consist of many important receptors and enzymes, will be 
valuable additions to the current biocircuit component library. The ability to 
prototype biocircuits involving membrane proteins in the TX-TL system will also be 
very beneficial to the field. 
Supplementary materials included in this thesis also provide helpful insights into 
our progress of prototyping biocircuits in TX-TL. Specifically: we successfully 
prototype additional feedforward loop circuit in the TX-TL; we characterize the 
strengths of a group of genetic terminators on linear DNAs in the TX-TL; and we 
show that TX-TL made membrane proteins can be refolded into correct 
conformations. 
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C h a p t e r  1  
PROTOTYPING AND IMPLEMENTATION OF A NOVEL FEEDFORWARD 
LOOP IN A CELL-FREE TRANSCRIPTION-TRANSLATION SYSTEM AND 
CELLS 
Abstract 
Building novel synthetic biological devices is a time-consuming task because of 
lengthy cell-based testing and optimization processes. Recent progress made in the 
cell-free field suggests that the utilization of mathematical models and cell-free 
transcription-translation testing platforms to systematically design and test novel 
synthetic biocircuits may help streamline some of the processes. Here we present a 
study of building a novel functional biological network motif from scratch with the 
aid of the mathematical modeling and the cell-free prototyping. In this work, we 
demonstrate that we were able to make a 3-promoter feedforward circuit from a 
concept to a working biocircuit in cells within a month. We started with performing 
simulations with a cell-free transcription-translation simulation toolbox. After 
verifying the feasibility of the circuit design, we used a fast assembling method to 
build the constructs and used the linear DNAs directly in the cell-free system for 
prototyping. After additional tests and assemblies, we implemented the circuit in 
plasmid forms in cells and showed that the in vivo results were consistent with the 
simulations and the outcomes in the cell-free platform. This study showed the 
usefulness of modeling and prototyping in building synthetic biocircuits and that we 
can use these tools to help streamline the process of circuit optimizations in future 
studies.
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1.1 Introduction 
Traditional methods for building synthetic biological circuits are labor-intensive and 
time-consuming [25]. Recent research progress on a cell-free bimolecular breadboard 
platform provides us with a potential tool to perform fast circuit prototyping in  
vitro [22-24]. The Escherichia coli-based cell-free transcription-translation system 
(TX-TL) is a “biomolecular breadboard” that allows us to quickly design, build, 
test, and debug novel synthetic biocircuits in vitro [20, 21]. Like a wind tunnel is 
to airplanes or a breadboard is to electronic circuits, TX-TL allows a biological 
engineer to quickly test, debug, and retest their biological circuits in vitro, 
bypassing the time-consuming steps of cloning, transformation, and cell growth, 
which are required for in vivo testing.  
TX-TL is a cell-free system based on S30 cell extracts. The extracts have been 
optimized for in vitro biocircuits testing, which means it mimics the E. coli in vivo 
characteristics while preserving transcription, protein production capability, and 
regulatory mechanisms [20, 21]. Previous work has shown that, besides plasmids, 
linear DNAs can also be used in TX-TL for fast circuit prototyping with the 
protection from the RecBCD inhibitor bacteriophage gamS protein [22, 26]. 
Combine this with the mathematical modeling, and it is possible to rapidly design 
and characterize functional synthetic biocircuit modules, such as the gene regulation 
network motifs, in TX-TL. 
Gene regulation networks are composed of a small set of recurring interaction 
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patterns called network motifs [27, 28]. Among all the common gene regulation 
network motifs, the incoherent type-1 feedforward loop (FFL) is one of the widely 
used and interesting ones [29]. This specific FFL is composed of two input 
transcription factors, one (𝑥 ) of which activates the other (𝑦), and both jointly 
regulate (activate or repress) a target gene (𝑧) (Figure 1A). Because there is a time 
delay between the activation of 𝑧 by 𝑥  and the repression of 𝑧 by 𝑦, it has been 
shown that this type of FFL can generate a temporal pulse of 𝑧 response.  
Using this FFL as an example, here we demonstrate the process of using a 
mathematical model and the TX-TL prototyping platform to build novel synthetic 
biocircuits and characterize their behaviors. First, we verified our circuit design by 
Figure 1: Diagrams of feedforward loops. A: The original feedforward loop 
illustration, composing of three components 𝑥, 𝑦 and 𝑧. Arrows mean activation and 
bars mean repression. B: The adapted feedforward loop illustration, with additional 
input 𝑢 to control the start of the activation. C: The actual biocircuit design for the 
feedforward loop. The activator AraC is at the 3’ of a constitutive promoter pCon. 
Arabinose is the inducer input. The repressor is controlled by the promoter pBAD, 
which is regulated by AraC/arabinose. The reporter deGFPssrA is at the 3’ of a 
combinatorial promoter pBAD-tetO, which can be activated by AraC/arabinose but 
can also be repressed by TetR. 
!
"#
!
"#
$A B C AraC	pCon
TetR
pBAD
deGFPssrA
pBAD-tetO
Arabinose
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6 
performing simulations in a cell-free transcription-translation toolbox (TX-TL 
toolbox) [30]. Next, we built the constructs based on the verified design using a fast 
assembly method [31] and then we used the linear DNAs of these constructs directly 
for test in the TX-TL [21, 22]. After additional tests and assemblies, we implemented 
the FFL circuit in vivo and saw consistent results as in silico and in vitro. This study 
brought attention to utilizing mathematical models and the TX-TL prototyping 
platform when designing novel synthetic biocircuits. Instead of building and testing 
circuits directly in cells, we can save significant amounts of man-hours and 
streamline some of the prototyping steps involved in building new network motifs by 
properly employing this TX-TL system. 
1.2 Circuit design and simulations 
To make things simpler in both TX-TL and subsequent cell-based tests, we first 
optimized the circuit design. Instead of having 𝑥 directly turning on 𝑦 and 𝑧, we 
added another component (𝑢 ) to the circuit for better control (Figure 1B). For  
TX-TL and especially cell-based tests, we will put all three components of the circuit  
(𝑥, 𝑦, and 𝑧) into the testing platforms in the beginning. In order to control when the 
circuit should start the dynamics, an extra input is required. Without the presence of 
the input 𝑢, 𝑥 cannot activate any of the downstream components. But as soon as 𝑢 
is added, the complex [𝑥: 𝑢] will activate both 𝑦 and 𝑧 and initiate the dynamics.  In 
this case, the activation of 𝑦 and 𝑧 is positively correlated with 𝑢, and 𝑢 can be seen 
as an inducer that is required for 𝑥 to activate the downstream parts. 
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Having the basic design in mind, we looked for biological parts that would fit the 
requirements stated above. We decided to use the AraC-arabinose activation system 
as 𝑥: 𝑢  [32], a transcription factor TetR as the repressor 𝑦  [33] and deGFP 
fluorescent protein with the corresponding combinatorial promoter as output 𝑧 [34] 
(Figure 1C). The transcription factor AraC binds to the promoter pBAD and activates 
the transcription of downstream genes (TetR and deGFP) only in the presence of the 
inducer arabinose. On the other hand, the transcription factor TetR binds to operator 
site tet and represses the transcription of deGFP. A small molecule 
anhydrotetracycline (aTc) can be used to sequester TetR proteins away from the 
operator and resume the transcription. Because of the time delay between the 
activation by AraC-arabinose and the repression by TetR, the deGFP gene will first 
be transcribed, and only after TetR proteins accumulate to certain threshold level 
(aTc can be used to extend the delay), the transcription of deGFP ceases. At the same 
time, the degradation ssrA tag on the deGFP protein leads to degradation of the  
protein [35]. As a result, the green fluorescence signal, which can be measured, will 
first increase and then decrease, generating a pulse-like behavior (Figure 2A). 
Simulations were performed using the TX-TL toolbox [30]. By tuning the 
parameters in the toolbox model, we verified the feasibility of our design through 
simulations. In Figure 2A, we can see that the model captures the pulse-like behavior 
of deGFP protein concentration, along with the increasing activator AraC 
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concentration and repressor TetR concentration. The delay in the increase of TetR 
concentration and the degradation of deGFP proteins result in the pulse-like behavior 
in deGFP concentration.  
In both the mathematical model and the TX-TL platform, we have fully control 
over the initial DNA concentrations for all the components. That gives us the freedom 
to change the circuit dynamics by simply changing the inputs – DNA concentrations.  
In Figure 2B, we tested how the varied concentrations of the repressor TetR DNA 
can affect the deGFP dynamics with all the other components as constants. As the 
simulation result shows here, increasing TetR DNA concentrations not only brings 
down the peak deGFP concentrations, but also shifts the peak to the left, suggesting 
Figure 2: Simulation results of the FFL using the TX-TL simulation toolbox. A: 
Simulation of the time course of the arbitrary protein concentrations for all three 
circuit components. Initial AraC, TetR and deGFP DNA concentrations are set to be 
the same at 1. Arabinose concentration is also set to 1. AraC, which is controlled by 
a constitutive promoter, is assumed to be produced in a linear fashion. The pBAD 
promoter controlling deGFP is set to be stronger than the pBAD promoter controlling 
TetR, in order to extend the delay and produce significant amount of deGFP proteins. 
B: Simulation of the time course of the deGFP protein concentrations with varied 
initial TetR DNA concentrations from 1 nM to 10 nM. Initial conditions for AraC 
and deGFP were 10 nM and the arabinose concentration was set to be 0.2%. 
A
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that it takes less time for TetR protein to accumulate to the threshold level when there 
is more initial TetR DNA.  
1.3 Linear DNAs and plasmids construction and prototyping in TX-TL 
After verifying the circuit design using simulations, we decided to build the 
incoherent type-1 FFL shown in Figure 1C. We first designed and ordered primers 
(a day before) to amplify the coding sequences for AraC, TetR, and deGFPssrA. Then 
we used the GoldenBraid assembly method to stitch specific promoters, ribosome 
binding sites (RBSs), coding sequences (CDSs) and terminators together with 
plasmid vectors [31]. After 1 hour incubation, we amplified the linear DNAs 
containing Promoter-RBS-CDS-Terminator-Vector via PCR reactions. Then we 
used these linear DNAs to run experiments in TX-TL directly with the presence of 
gamS. From start to finish, one experiment cycle can be less than a day. 
TX-TL experiments were run by simply mixing the extract and buffer with the 
inputs – DNAs (AraC, TetR and deGFP) and the inducer arabinose [21]. After mixing 
all together, GFP fluorescence was measured using a plate reader. Figure 3A showed 
the experimental results from TX-TL experiments. All the curves were consistent 
with the simulation: GFP signal first increased as a result of AraC-arabinose 
activation; then after TetR proteins accumulated to the threshold amount, they 
repressed the transcription of deGFPssrA and at the same time, ClpX protein, which 
is an ATPase, unfolded the tagged deGFP proteins and caused the reduction of GFP 
signal [36]. As we can also see in the figure, the more the TetR DNAs were added, 
Chapter 1 
 
 
 
10 
the lower the GFP signal was and the faster the signal reached peak; this is also 
consistent with our simulations. However, it is easy to notice that the steady state 
GFP protein concentrations for different initial TetR DNA concentrations were 
different. This is because TX-TL reactions have limited resources, including RNA 
polymerases, NTPs, ribosomes, and amino acids [37]. The energy required for ClpX 
Figure 3: Experimental results of the FFL in TX-TL and cells. A: The time course 
result of the FFL experiment in TX-TL with linear DNA: 10 nM AraC linear DNA, 
10 nM deGFP linear DNA, 10 nM ClpX linear DNA, 0.2% arabinose, 0.1 µg/mL aTc 
and varied TetR linear DNA concentrations. Experiments were run at 29°C. B: The 
time course result of the FFL experiment in TX-TL with plasmid DNA: 2 nM AraC-
TetR-deGFPssrA plasmid, 1 unit of purified ClpX protein, 0.2% arabinose and 0.01 
µg/mL aTc. Experiments were run at 29°C. C, D: The time course results of the FFL 
experiments in cells. C: deGFP protein is tagged with ssrA degradation tag. D: 
deGFP does not have a degradation tag. GFP signals, which were average from three 
independent repeated wells, were measured using a plate reader and then data were 
normalized using OD600 readings to get the fluorescence reading for each cell. The 
concentration of the inducer arabinose is 0 or 0.2%. Experiments were run at 37°C. 
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to unfold tagged deGFP proteins will run out gradually, and the resources will get 
used up faster when more DNAs are in the reaction. As a consequence, the GFP 
concentrations showed different steady state levels.  
After we tested the linear DNA version of the FFL in TX-TL and found a working 
design, we assembled these linear DNAs into one plasmid using GoldenBraid 
assembly method in order to implement the circuit in cells. Before testing the plasmid 
version of FFL in vivo, we first evaluated the construct in TX-TL, as it is fast and 
convenient to set up TX-TL experiments and there is no need for the time-consuming 
step of growing cells. Figure 3B showed the results of the plasmid version of the FFL 
in TX-TL. The dynamics of the circuit were again consistent with those from both 
simulations and linear DNA circuit, suggesting that this specific circuit design had a 
good chance to work in cells. 
1.4 Implementation of the biocircuit in cells 
Following the test of expressing plasmid version of the FFL in TX-TL, we 
transformed that plasmid into E. coli cells. In addition, to make sure the decrease of 
GFP signal in vivo is specific to the GFP degradation by ClpX instead of the dilution 
introduced by cell division, we had a control circuit, in which the deGFP was not 
tagged with ssrA degradation tag. Figure 3 showed the experimental results from in 
vivo experiments of the FFL circuit (Figure 3C) and the control circuit (Figure 3D). 
The dynamics shown in Figure 3C were clearly consistent with those shown in  
TX-TL experiments, meaning the FFL prototyped in TX-TL indeed showed the same 
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behavior in vivo. In contrast, the control circuit in Figure 3D did not exhibit a pulse-
like behavior, suggesting that the pulse we saw in Figure 3C was not a result of 
dilution but was caused by the degradation of the GFP proteins.  
1.5 Discussion 
The idea of the cell-free TX-TL platform is not new, as there have been many studies 
on the original S30 cell extract since it first came out in the 1960s [38, 39]. However, 
most of the cell-free extracts were focusing on protein expression as an alternative 
option to making proteins in cells [40]. This specific TX-TL platform was developed 
with the goal of prototyping synthetic biocircuits in mind. TX-TL, along with the 
mathematical toolbox developed for it, can be the prototyping breadboard for 
synthetic biology. This work, together with other publications [20, 22-24, 37], serves 
as a testimony for that ambition. Expressing transcription factors and have them 
turning certain components on or off has been demonstrated before; but prototyping 
a synthetic biocircuit with spontaneous dynamics built in, such as an incoherent  
type-1 feedforward loop, is challenging. By tuning the parameters used by the 
mathematical model, we could get a sense of what strength of promoters and 
ribosome binding sites should be used in the actual biocircuit. Then we had to spend 
some amount of time characterizing specific parts, such as promoters, ribosome 
binding sites and coding sequences individually in TX-TL. From this preliminary 
parts library, then we could assemble our constructs and test the actual components 
in TX-TL. Because of the fast iteration time of this platform, we were able to finish 
all the above and the final implementation in cells within a month. Compared to the 
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first generation of biocircuits, we have shortened the development time  
significantly [4, 5]. We have also optimized a variant FFL circuit composed of a 
different activator in TX-TL and in cells (see “Implementation of the feedforward 
loop composed of LasR and pLas” in Supplementary Materials for details). 
There are limitations to this protocol. First, there are limited resources in the TX-
TL reactions and on top of that, there is competition of different components for the 
same transcription and translation machineries. One way to avoid this limitation is to 
set up reactions in compartments that only allow small molecules exchanges so that 
some resources, such as amino acids and NTPs, can be replenished. Second, it is 
challenging to use TX-TL data quantitatively to deduce the results in cells. Cell-free 
systems, no matter how we justify it, are different from cells. When TX-TL is used 
to help with prototyping novel synthetic biocircuits, it is recommended that the 
results are examined qualitatively instead of quantitatively. Although the absolute 
strengths of certain promoters and RBSs are different between TX-TL and cells, their 
relative strengths are comparable between the two systems. Third, the TX-TL 
simulation toolbox has its uncertainty and arbitrariness. The parameters used in the 
toolbox might not be physiologically reasonable despite the fact that we tried to refer 
to as many literature available parameters as possible. However, qualitatively we can 
use the simulation results as a reference; for example, we need one promoter to be 
stronger than the other promoter in order to achieve the desired dynamics and then 
we can have this information in mind when we design the actual biocircuits. In 
summary, though it is not a platform without its limitations, TX-TL could certainly 
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be used for rapid preliminary characterization and prototyping of synthetic 
biocircuits.  
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Materials and Methods 
Cell-free experiment preparation and execution  
Preparation of the cell-free TX-TL expression system was done according to 
previously described protocols [21], resulting in extract with conditions: 8.9 – 9.9 
mg/mL protein, 5 mM Mg-glutamate, 40 mM K-glutamate, 1.5 mM each amino acid 
except leucine, 1.25 mM leucine, 50 mM HEPES, 1.5 mM ATP and GTP, 0.9 mM 
CTP and UTP, 0.2 mg/mL tRNA, 0.26 mM CoA, 0.33 mM NAD, 0.75 mM cAMP, 
0.068 mM folinic acid, 1 mM spermidine, 30 mM 3-PGA, 2% PEG-8000.  
TX-TL reactions were conducted in a volume of 10 µL in a 384-well plate (Nunc 
MicroWell 384-well optical bottom plates) at 29°C, using a three-tube system: 
extract, buffer, and DNA. When possible, inducers such as arabinose or purified 
proteins such as gamS [26] were added to a mix of extract and buffer to ensure 
uniform distribution. For deGFP, samples were read in a Synergy H1 plate reader 
(Biotek) using settings for excitation/emission: 485 nm/525 nm, gain 61 or 100. All 
samples were read in the same plate reader, and for deGFP relative fluorescent units 
were converted to either nM (for TX-TL) or Normalized Fluorescent Unit (NFU for 
in vivo) using a purified deGFP-His6 standard to eliminate machine to machine 
variation (different Bioteks). 
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PCR product preparation and plasmid DNA assembly  
Linear DNA fragments were amplified using Pfu Phusion Polymerase (New England 
Biolabs), DpnI digested for 5 min at 37°C (New England Biolabs) while verified with 
agarose gel electrophoresis, and PCR purified using previously described procedures. 
Fragments were then assembled in vitro using Golden Gate assembly. For Golden 
Gate assembly, a 15 µL reaction was set up consisting of equimolar amounts of vector 
and insert, 1.5 µL 10X NEB T4 Buffer (New England Biolabs), 1.5 µL 10X BSA 
(New England Biolabs), 1 µL BsaI (New England Biolabs), and 1 µL T4 Ligase at 2 
million units/mL (New England Biolabs). Reactions were run in a thermocycler at 
10 cycles of 2 min/37°C, 3 min/20°C, 1 cycle 5 min/50°C, 5 min/80°C. For Golden 
Gate assembly, constructs with internal BsaI cut sites were silently mutated 
beforehand using a QuikChange Lightning Multi Site-Directed Mutagenesis kit 
(Agilent). For both methods, assembled circular DNAs were transformed into 
electrocompetent or chemically competent cells: a KL740 strain (lab made competent 
strain) if using an OR2-OR1 promoter (29°C), a MG1655 strain (lab made competent 
cells) for circuit testing, and a JM109 strain (Zymo Research) for all other constructs. 
KL740 upregulates a temperature sensitive lambda cI repressor. PCR products were 
amplified using Pfu Phusion Polymerase (New England Biolabs) for all constructs, 
and were DpnI digested. Plasmids were miniprepped using a Qiagen mini prep kit. 
All plasmids were processed at stationery phase. Before use in the cell-free reaction, 
both plasmids and PCR products underwent an additional PCR purification step 
using a QiaQuick column (Qiagen), which removed excess salt detrimental to TX- 
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TL, and were eluted and stored in 10 mM Tris-Cl solution, pH 8.5 at 4°C for short-
term storage and −20°C for long-term storage. All the plasmids used in the work can 
be found on https://www.addgene.org/.  
In vivo experiment  
All in vivo experiments were performed in E. coli strain MG1655. Plasmid 
combinations were transformed into chemically competent E. coli MG1655 cells, 
plated on Difco LB+Agar plates containing 100 µg/mL carbenicillin and incubated 
overnight at 37°C. Plates were taken out of the incubator and three colonies were 
picked and separately inoculated into 5 mL of LB containing carbenicillin and/or 
chloramphenicol, and/or kanamycin at the concentrations above in a 14 mL Falcon 
Round-Bottom Polypropylene Tubes (Fisher Scientific), and grown approximately 
17 h overnight at 37°C at 200 rpm in a benchtop shaker. This overnight culture  
(100 µL) was then added to a new 14mL tube containing 5 mL (1:50 dilution) of 
Minimal M9 casamino acid (M9CA) media [1X M9 salts (42 mM Na2HPO4, 24 mM 
KH2PO4, 9 mM NaCl, 19 mM NH4Cl, 1 mM MgSO4, 0.1 mM CaCl2, 0.5 µg/ml 
thiamine, 0.1% casamino acids, 0.4% glycerol) containing the selective antibiotics 
and grown for 4 h at the same conditions as the overnight culture. Then 10 µL cultures 
were transferred to 96-well glass bottom plate with 290 µL M9 with corresponding 
experimental conditions. Plates were shaken and GFP fluorescence (485 nm 
excitation, 525 nm emission), and optical density (OD, 600 nm) were measured using 
a Biotek Synergy H1m plate reader at 37°C at the highest speed for 12 hours.  
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Supplementary Materials 
Implementation of the feedforward loop composed of LasR and pLas 
Besides the feedforward loop (FFL) circuit we designed, prototyped, and 
implemented in the main article, we also tested a FFL designed by Zachary Sun, 
which had AraC, arabinose, pBAD, and pBAD-tetO replaced by LasR, N-(3-
Oxododecanoyl)-L-homoserine lactone (AHL), pLas, and pLas-tetO, respectively. 
The circuit design is shown in Supplementary Figure S1. 
 
Supplementary Figure S1 Illustration diagram of the FFL 
composed of LasR. The arrows mean activation and the bars 
mean repression. 
The promoter J23151 is a constitutive promoter [41]. LasR protein, in the 
presence of the inducer AHL, becomes an activator that can turn on both pLas and 
pLas-tetO promoters. All the other components work like the AraC FFL, and the time 
course data of the LasR circuit from in vivo experiments are shown in Supplementary 
Figure S2. 
LasRJ23151
TetRpLas
GFPssrA
pLas-tetO
AHL
aTc
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Supplementary Figure S2 Time course data from the in vivo 
experiment of the LasR FFL circuit in MG1655 E. coli cells. 
Detailed experiment setup was described in the Materials and 
Methods. Briefly, 4 AHL concentrations were used in the 
experiment, from 0 to 100 nM. 20 ng/mL of aTc was added to 
all of them. GFP fluorescence and OD600 measurements were 
done using a Biotek plate reader. GFP data was subtracted by the 
background and then normalized with OD data to get the 
normalized fluorescence unit (NFU). 
Though the LasR FFL works in a similar way as the AraC FFL, one problem with 
the LasR FFL circuit was that the aTc, which would bind to TetR proteins and 
sequester them away from tetO, had to be added to extend the delay to create 
significant pulses. This was due to the leaky expression of the pLas promoter. To 
make the circuit more robust, we engineered the pLas promoter to be more tightly 
controlled by LasR-AHL via prototyping different variants of pLas promoters in TX-
TL. The one we found working very robustly is shown in Supplementary Figure S3 
and the sequence of that pLas variant can be found on https://www.addgene.org/. As 
we can see in the figure, only when both LasR and AHL were added, we could see 
the activation of the pLas-GFP. Neither LasR nor AHL alone could activate the 
promoter and there was little to no leaky expression from the promoter itself. TetR 
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and aTc were tested to make sure that the pLas promoter, without the tetO part, could 
not be affected by them. 
 
Supplementary Figure S3 Time course of the selected pLas 
promoter with GFP at its 3’. Experiments were run with 10 nM 
pLas-GFP linear DNA with or without the additional 
components/inducers listed in the legend. If used, the pCon-
LasR linear DNA was 10 nM, pCon-TetR linear DNA was 10 
nM, AHL was 50 nM and aTc was 20 ng/mL.  The GFP 
fluorescence data was subtracted with background and then 
normalized using GFP protein calibration data on a Biotek plate 
reader. 
We then modified the LasR FFL circuit with this exact promoter and we were 
able to generate pulse-like behavior in cells without adding any aTc. The in vivo data 
is shown in Supplementary Figure S4. As we can see, when there was no AHL added, 
we got no response from the circuit. Only when we had significant activation caused 
by AHL (more than 50 nM in this case) would we see pulse-like behavior from the 
circuit in cells, and the highest peaks of the pulses were positively correlated with the 
inducer concentrations. 
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Supplementary Figure S4 Time course data from the in vivo 
experiment of the optimized LasR FFL circuit in MG1655 E. 
coli cells. Detailed experiment setup was described in the 
Materials and Methods. Briefly, 4 AHL concentrations were 
used in the experiment, from 0 to 100 nM. 20 ng/mL of aTc was 
added to all of them. GFP fluorescence and OD600 
measurements were done using a Biotek plate reader. GFP data 
was subtracted by the background and then normalized with OD 
data to get the normalized fluorescence unit (NFU). 
Not only did we test the circuit quantitatively in bulks, but we also examined the 
circuit behavior qualitatively in a microfluidic device, also known as the mother 
machine. The mother machine consists of a series of growth channels that can trap 
single bacterial cells inside, and is designed to allow growth medium to pass through 
at a constant rate, which results in diffusion of fresh medium into the growth channels 
as well as removal of cells as they emerge from the channels into the main  
trench [42]. As we can see in Supplementary Figure S5, while cells were growing 
and dividing in a narrow comb-like space, they showed green fluorescence intensity 
starting from weak to strong and then back to weak with the same media keeping the 
inducer AHL concentration constant at 50 nM. 
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Supplementary Figure S5 Microscope movie snapshots of the 
optimized LasR FFL. Each frame was taken 10 minutes apart. 
Cells were grown using the same in vivo method described in 
the Materials and Methods. Fluorescence microscopy imaging 
was performed on an Olympus IX81 inverted fluorescence 
microscope using a Chroma wtGFP filter cube (450/50 BP 
excitation filter, 480 LP dichroic beamsplitter, and 510/50 BP 
emission filter), with an XFO-citep 120 PC light source at 100 
% intensity and a Hamamatsu ORCA-03G camera. Cells were 
imaged using a 100x phase objective with oil. 
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C h a p t e r  2  
IMPLEMENTATION AND SYSTEM IDENTIFICATION OF A 
PHOSPHORYLATION-BASED INSULATOR IN A CELL-FREE 
TRANSCRIPTION-TRANSLATION SYSTEM 
Abstract  
An outstanding challenge in the design of synthetic biocircuits is the development of 
a robust and efficient strategy for interconnecting functional modules. Recent work 
demonstrated that a phosphorylation-based insulator (PBI) implementing a dual 
strategy of high gain and strong negative feedback can be used as a device to attenuate 
retroactivity. This paper describes the implementation of such a biological circuit in 
a cell-free transcription-translation system and the structural identifiability of the PBI 
in the system. We first show that the retroactivity exists in the cell-free system by 
testing a simple negative regulation circuit. Then we demonstrate that the PBI circuit 
helps attenuate the retroactivity significantly compared to the control. We consider a 
complex model that provides an intricate description of all chemical reactions and 
leveraging specific physiologically plausible assumptions. We derive a rigorous 
simplified model that captures the output dynamics of the PBI. We performed 
standard system identification analysis and determined that the model is globally 
identifiable with respect to three critical parameters. These three parameters are 
identifiable under specific experimental conditions and we performed these 
experiments to estimate the parameters. Our experimental results suggest that the 
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functional form of our simplified model is sufficient to describe the reporter 
dynamics and enable parameter estimation. In general, this research illustrates the 
utility of the cell-free expression system as an alternate platform for biocircuit 
implementation and system identification and it can provide interesting insights into 
future biological circuit designs.   
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2.1 Introduction 
The successful design and implementation of the inaugural biocircuits, such as the 
genetic toggle switch and the repressilator, have demonstrated the possibility of 
modularity in synthetic biological circuits [4, 5]. The recognition of functional 
modules makes building large and complicated synthetic biological circuits possible. 
Basic modules can be studied and tested in isolation and then can be connected with 
other modules to perform certain functions. However, the modularity of biological 
circuits can change when interconnections are made. This effect is called retroactivity 
and is a fundamental issue in systems engineering [43, 44]. This means that when a 
downstream system is connected to another system, the downstream system will 
affect the behavior of upstream component. As a result, the signal generated by the 
upstream component may not be effectively transferred to other components. 
Retroactivity can be divided into two types based on which signal it affects: the 
retroactivity to the input and the retroactivity to the output. Based on previous 
theoretical studies, an operational-amplifier-like orthogonal biomolecular device 
could help attenuate retroactivity [43]. An electronic operational amplifier absorbs 
little current from upstream; as a result, there is almost no voltage drop to upstream 
output. At the same time, the retroactivity to the output is attenuated because of a 
large amplification gain and an equally large negative feedback loop (Details are 
described in “Brief introduction on retroactivity and how to attenuate it” in 
Supplementary Materials). Based on these ideas and previous work [45], we tested 
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an insulator design using nitrogen regulation proteins [46] in a cell-free transcription-
translation (TX-TL) system. 
The TX-TL system developed in [20, 21] is an attractive candidate platform for 
such rapid prototyping. The system facilitates DNA-based expression on plasmids 
and linear DNA, and since linear and plasmid DNA can be prepared and expressed 
in the TX-TL system in a single day’s time [22], the time required to iterate over 
designs is considerably reduced. 
Another powerful aspect of the TX-TL system is the ability to directly modulate 
the concentration of different pieces of DNA encoding different biocircuit 
components. The ability to rapidly synthesize and test the effect of different promoter 
sites, ribosome binding sites, and other components, and simultaneously vary the 
DNA encoding these parts, permits a degree of freedom typically absent in cell-based 
assays. In this setting, iterating of prototypes can be assisted by predictive modeling 
of biocircuit dynamics. It is the ability to control DNA concentrations and rapidly 
vary structural properties of the biocircuit that allow us to address the problem of 
parameterizing a predictive model. 
Cell-free systems have long been used to characterize fundamental parameters in 
biological systems [47]. In a synthetic biology context, especially for the 
phosphorylation-based insulator circuit, it is unclear what parametric information can 
be extracted from a series of systematic tests in an in vitro system, specifically the 
TX-TL system. With additional degrees of freedom in the experimental conditions, 
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the TX-TL system may be able to provide insight into model parameters that in vivo 
studies could not. Moreover, it is unclear what systematic tests should be carried out 
in order to retrieve this information. This paper investigates these issues using the 
phosphorylation-based insulator as a case study. 
In general, a parametric model is globally structurally identifiable only under 
certain mathematical conditions [48]. These conditions are valid as long as the control 
variables enter the dynamical system as a multiplicative perturbation. However, as 
we will see with the phosphorylation-based insulator, even if the model retains this 
structure the model may not be globally identifiable because of the large number of 
parameters it contains, despite having only a couple output variables. As is often the 
case, a first principles model may be physically representative of the intricate 
reactions happening in the system, but carry a complexity that far exceeds the 
information present in the data. Thus, simplified models that are reflective of the low-
dimensional output data, while also retaining the (controllable) experimental 
variables in the TX-TL system, are desirable. 
In this work, we successfully implement the PBI circuit in TX-TL and further 
propose a complex model based on the fundamental processes of transcription, 
translation, and phosphorylation. The model is unwieldy to analyze so we rigorously 
derive a simplified model based on a series of physically realistic assumptions, show 
that it is globally identifiable with respect to the data, and perform a series of 
experimental perturbation tests to back out the simplified model parameters. 
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The main contributions of this work are the following: 1) we demonstrate that the 
TX-TL system can be used to prototype relatively complicated synthetic biocircuits, 
such as the PBI circuit that involves not only transcriptions, translations, and protein-
DNA interactions but also post-translated interactions like phosphorylation and 
dephosphorylation; 2) we show that by utilizing the TX-TL system that has extra 
degrees of freedom compared to cell-based systems, we can systematically identify 
the parameters of our mathematical models using actual experimental data, which 
subsequently guide us to achieve more efficient circuit prototyping and better future 
circuit designs [49, 50]. 
2.2 Demonstration of Retroactivity in TX-TL 
Firstly, we wanted to demonstrate retroactivity in the TX-TL system. The example 
we used is a simple negative regulation circuit, in which constitutively expressed 
TetR proteins repress the transcription of downstream components pTet-GFP and 
pTet-RFP DNA unless an inducer aTc is added (Figure 1A). Here, we considered 
pTet-GFP as the reporter and pTet-RFP as the load. When there is no inducer present, 
the reporter will remain off because of the repression by TetR. However, if we added 
a significant amount of load into the system, the load sequesters the TetR proteins 
from pTet-GFP, resulting in the activation of GFP transcription (Figure 1B). This is a 
result of retroactivity, in which downstream components affect the behavior of the 
upstream system output. We next tested this effect in the presence of different inducer 
concentrations (Figure 1C). At low aTc concentrations (less than 0.5 µg/mL), as load 
concentration increased, GFP expression increased because of retroactivity.  
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Figure 1 Demonstration of the retroactivity in the TX-TL system. A: Circuit 
diagram of a negative regulation circuit. B: Time traces of the GFP 
fluorescence in presence of different concentrations of RFP DNA. As RFP 
DNA concentrations increase, more GFP fluorescence can be detected as a 
result of the retroactivity. Error bars are standard deviations from 3 repeats. 
C: Titration of TetR repressor aTc in presence of different concentrations of 
RFP DNA. X axis is the final concentrations of aTc in each sample and Y 
axis is the end point GFP fluorescence of the corresponding samples. Data 
were collected using a plate reader with settings for excitation/emission: 485 
nm/525 nm. 
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However, if too much aTc was added, GFP expression actually decreased as load 
increased. This is because resources in TX-TL, such as ribosomes and RNA 
polymerase, are limited.  
This simple circuit demonstrates that there is retroactivity in biological circuits 
in the TX-TL system. To address this problem, we implement an insulator component 
to compensate for the retroactivity. 
2.3 Demonstration of the Insulation Capability of the PBI Circuit 
Based on the insulator design in [45], we adapted a simpler form to implement an 
insulator in the TX-TL system (Figure 2A). The insulator design is based on a well-
known two-component signal transduction system regulating the transcription of 
genes encoding metabolic enzymes and permeases in response to carbon and nitrogen 
status in E. coli and related bacteria [51]. There are two essential proteins in the 
system: NRII and NRI (NtrB-NtrC). NRI can be phosphorylated into NRIP by NRII 
(kinase form). Only NRIP is able to activate the s54-dependent promoter glnA and 
trigger the transcription of downstream genes [52]. NRII is both a kinase and 
phosphatase, regulated by the PII signal transduction protein, which, on binding to 
NRII, inhibits the kinase activity of NRII and activates the NRII phosphatase  
activity [53]. NRII is known to form dimers and will autophosphorylate itself to 
become a kinase. Previous studies suggested that when NRII has a mutation of 
leucine to arginine at residue 16, it loses its phosphatase activity but shows normal 
autophosphorylation. In contrast, NRII with a H139N mutation is not able to transfer  
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Figure 2 Implementation of the PBI circuit in the TX-TL system. A: Circuit 
diagram of the PBI circuit. pCon is a constitutive promoter. B: Transfer 
function curves for controls and insulators with or without load DNA. Raw 
GFP fluorescences were normalized using the highest GFP fluorescences 
from controls and insulators, respectively (highest GFP = 1). Compared to 
the control with load, which only had 40% signal left, the insulator with load 
was able to preserve 80% of the signal, significantly attenuating the 
retroactivity. C: Fold changes of the samples without load over the ones with 
load. The insulator samples have significantly smaller fold changes 
compared to those of the control samples. 
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the phosphoryl group from its active site histidine to an aspartate side chain of  
NRI [51]. As a result, NRIIL16R only acts as a kinase and NRIIH139N only 
functions as a phosphatase.  
In our circuit design, proteins NRI, NRIIL16R, and NRIIH139N are all 
constitutively expressed. Reporter GFP is controlled by the s54-dependent promoter 
glnA, which is activated by phosphorylated NRI. We also confirmed that the 
phosphorylation-dephosphorylation loop worked in TX-TL (Supplementary  
Figure S1). By virtue of the fast timescale of phosphorylation and dephosphorylation 
loop, this circuit enjoys a large amplification gain and an equally large negative 
feedback mechanism as mentioned in the introduction, which makes it a promising 
insulation device. 
To test the insulation capability of our insulator, we compared the behaviors of 
the insulator circuit with a control circuit that does not have a large amplification 
gain, nor a negative feedback loop. As mentioned in previous theoretical  
studies [43], the insulator circuit requires abundant substrate NRI to achieve high 
gain. So we added 47.5 nM NRI linear DNA in the insulator circuit and only 5 nM in 
the control circuit. But to take resource limitations into account, we balanced the 
insulator and control by adding 42.5 nM of extra DNA (pTet-RFP) in the control 
circuit. Then we varied the amount of downstream glnA promoters by adding 0 nM 
(without-load) or 20 nM (with-load) pGlnA-RFP linear DNA, which would introduce 
retroactivity. We then titrated with different concentrations of NRIIL16R (kinase) 
linear DNA. After data was collected using a plate reader, the GFP relative 
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fluorescence unit of the control and insulator circuits were normalized using their 
highest without-load fluorescence readings, respectively. As shown in Figure 2B, 
when the control circuit was added with load DNA, the GFP expression dropped 
significantly (by about 60% at the highest kinase DNA concentration). In contrast, 
the insulator circuit only showed about a 20% decrease in the GFP expression when 
the load was added at the highest kinase DNA concentration. Figure 2C simplifies 
the four curves into two curves by looking at the fold changes of without-load 
samples over with-load samples. As we can see, the insulator samples have much 
smaller fold change between without-load and with-load samples compared to the 
control samples, indicating the attenuation of the retroactivity by the PBI circuit. 
These results suggest that the insulator does help attenuate the retroactivity in 
biological circuits in TX-TL platform.  
Besides, we also investigated the temperature sensitivity of this circuit in TX-TL. 
We performed the same experiments at 29°C, 33°C, and 37°C, respectively 
(Supplementary Figure S2). At 29°C, the PBI circuit was able to limit retroactivity to 
about 20%; however, as temperature increased, the efficiency of insulation decreased 
to about 40% and 50%; while the control circuit had the same signal reduction among 
all three temperatures. The results suggested that the PBI circuit is sensitive to 
reaction temperature in TX-TL and its performance is affected by the temperature. 
Previous TX-TL characterization experiments suggested that relatively higher 
temperature would accelerate the molecular reactions involved in transcription and 
translation, resulting in faster GFP production rate [37]. However, because of the 
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resource limitation in TX-TL, there could be more intensive competition on resources 
at higher temperature. As a result, the downstream load might have a better chance 
to sequester the NRI proteins away from the reporter at higher temperature, which 
would lead to less attenuation of the loading effect. 
2.4 Estimation of Constitutively Expressed Protein Concentrations 
In this section, our goal is to derive a simplified model that can be uniquely 
parameterized from a set of characterization experiments in the bimolecular 
breadboard system [20, 21]. We base our model on the general phosphorylation-
based insulator model posed in [43], but adapt our notation and augment input 
variables that are present in the biomolecular breadboard system. Because it is an in 
vitro system, the total DNA and inducer concentration in solution are adjustable 
experimental variables or variables that can be modeled as inputs. It is the freedom 
of these inputs that allows us to perform experiments and collect data that 
parameterizes the model. 
We begin by introducing a chemical reaction model for the system: 
Equation 1 
                                𝑁𝑅𝐼 + 𝐾	 @AB 	𝑁𝑅𝐼C + 𝐾, 
                            𝑁𝑅𝐼C + 𝑃ℎ	 @EFAB 	𝑁𝑅𝐼 + 𝑃ℎ, 
                                      𝑁𝑅𝐼C 	@GHIJ 	𝑁𝑅𝐼, 
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                                           𝑝L 	@MN,P 	𝑚L 	@MR,P 𝐾S 	@T,P 	𝐾, 
                                         𝑝CU 	@MN,VB 	𝑚CU 	@MR,VB 𝑃ℎS 	@T,VB 	𝑃ℎ, 
                                        𝑝WXY 	 @MN,Z 	𝑚WXY 	@MR,Z 𝑁𝑅𝐼S 	@T,Z 	𝑁𝑅𝐼, 
                                          𝑚L 	[\ 	∅,  𝑚CU 	[\ 	∅,  𝑚WXY 	 [\ 	∅, 
                       𝑁𝑅𝐼C +	𝑝^_`a 	 @H@b 	𝑁𝑅𝐼C: 𝑝^_`a 	@cGI 	𝑁𝑅𝐼C +	𝑝^_`a + 𝐺𝐹𝑃, 
                     𝑁𝑅𝐼C +	𝑝^_`a,d 	 @H@b 	𝑁𝑅𝐼C: 𝑝^_`a,d 	 @cGI 	𝑁𝑅𝐼C +	𝑝^_`a,d + 𝑅𝐹𝑃, 
where 𝐾, 𝑃, 𝑁𝑅𝐼,	 and 𝑁𝑅𝐼C denote the kinase, phosphatase, unphosphorylated NRI, 
and phosphorylated NRI protein, pGlnA is the GlnA promoter, pGlnA,L is the GlnA 
promoter encoding for other competing genes, 𝑁𝑅𝐼S is the unfolded form of NRI 
protein, 𝐾S is the unfolded form of kinase, 𝑃ℎS is the unfolded form of phosphatase, 
and ∅ represents a macro state of all degraded mRNA. We also use the notation 𝑋fgf 
when needed to denote the total amount of protein 𝑋, where 𝑋	 = 	𝐾, 𝑃ℎ, 𝑁𝑅𝐼. This 
notation will be convenient for our analysis in the sequel. 
Since 𝑝i  represents a constitutive promoter for 𝑋	 = 	𝐾, 𝑃ℎ, 𝑁𝑅𝐼 , the total 
kinase, phosphatase, and NRI protein are produced constitutively. An assay with GFP 
shows that without additional proteases added into the bimolecular breadboard 
system, protein degradation is negligible [22]. Thus, we can approximate the total 
amount of NRI protein at a particular time 𝑡 expressed under the pCon promoter 
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using GFP expression expressed under the same promoter and ribosome binding site 
(RBS) as a proxy. This total amount of NRI, we will denote as 𝑁𝑅𝐼fgf. 
We also note that an alternative approach to estimate 𝑁𝑅𝐼fgf(𝑡) is to assay the 
expression of a NRI-GFP fusion protein. However, this approach may significantly 
alter the phosphorylation dynamics of the NRI protein, since it acts as a substrate for 
the kinase. Therefore, we will express GFP separately on the pCon promoter with the 
same RBS and use it to estimate concentration from arbitrary units of fluorescence. 
Because there are differences in the transcription and translation rates, and 
folding of GFP and NRI, we do not expect the estimated concentration of GFP at time 𝑡 will be identical to the concentration of the NRI protein at time 𝑡. We can account 
for these differences dynamically in a mass action model of NRI and GFP dynamics. 
If we consider NRI constitutive expression in a simple isolated system with no kinase 
or phosphatase activity 𝑁𝑅𝐼fgf, e.g. with the chemical reaction system 
𝑝lg` 	@MN,Z 	𝑚WXY 	@MR,Z 𝑁𝑅𝐼S 	@T,Z 	𝑁𝑅𝐼, 
we see that 
𝑑𝑁𝑅𝐼𝑑𝑡 = 	𝑘n,W𝑁𝑅𝐼S,	𝑑𝑁𝑅𝐼S𝑑𝑡 = 	𝑘od,W𝑚WXY,	𝑑𝑚WXY𝑑𝑡 = 	𝑘oi,W𝑝lg`	–	𝛿r𝑚WXY. 
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The total NRI protein at time 𝑡 is ultimately a function of 𝑚WXY(𝑡). Since the 
dynamics of 𝑚WXY can be viewed as a scalar linear system with static step input pCon, 
we can solve analytically for 𝑁𝑅𝐼fgf(𝑡) to obtain: 
Equation 2 
𝑁𝑅𝐼 𝑡 = 𝑁𝑅𝐼 𝑡t + 𝑘n,W 𝑁𝑅𝐼S𝑑𝜏ft 	
= 𝑁𝑅𝐼 𝑡t + 𝑘n,W 𝑁𝑅𝐼S 𝑡t + 𝑘od,W𝑚WXY 𝑑𝜉wt 𝑑𝜏ft 	= 𝑁𝑅𝐼 𝑡t
+ 𝑘n,W 𝑁𝑅𝐼S 𝑡tft
+ 𝑘od,W𝑚WXY 𝑡t + 𝑘od,W𝑘oi,W𝑝lg` 1 − 𝑒{[\|𝛿r 𝑑𝜉wt 𝑑𝜏	
= 	𝑘n,W𝑘oi,W𝑘od,W𝛿r 𝑝lg` 𝑡}2 − 1𝛿r} 𝑒{[\f , 
whenever 𝑁𝑅𝐼(𝑡t) 	= 	𝑚WXY(𝑡t) 	= 	𝑁𝑅𝐼S(𝑡t) 	= 	0 . To reflect the experimental 
conditions of our system, we have assumed that the initial mRNA, unfolded and 
folded kinase, phosphatase, and NRI concentrations are zero. Notice that in deriving 
this expression, we have made no assumption about time-scale separation. While 
such arguments are valid since the folding dynamics proceed at a much slower rate 
than the transcription and translation dynamics, they are unnecessary for estimating 
NRI at time 𝑡 . Finally, it is worth noting that we assume the transcription and 
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translation reactions proceed as first order reactions, which is valid as long as our 
DNA concentrations (typically in the nM range) are much less than the 
concentrations of RNA polymerases, ribosomes, chaperone proteins, etc. (typically 
in the µM range [20]). 
It is worth noting that model for the mRNA species 𝑚WXY  is qualitatively 
consistent with our experimental studies of mSpinach expression in the transcription-
translation system. To demonstrate this, we consider a model of the same functional 
form as equation 2, but with a constitutive promoter and coding sequence of the same 
length as the mSpinach transcript. This yields 
𝑚 𝑡 = 	 @MNJ[\ (1 − 𝑒{[\f), 
where 
𝑘oi = 	 𝑘,𝐿(𝑚) 𝑘gr 
is estimated with 𝑘, 	= 	60	𝑏𝑝/𝑠 (the approximate mean of a variety of media-
dependent rates found in [54]), 𝐿 𝑚 = 	98	𝑏𝑝/𝑛𝑀  is the length of mSpinach 
aptamer without a tRNA scaffold [55], and 𝑘gr 	= 	6.3´10{}	𝑠{ is the forward 
rate of open complex formation from the closed complex.  
From this, it is possible to estimate the rate of mRNA degradation,  
𝛿r = 	 @MNJr(f}t) = 3×10{}𝑠{, 
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where 𝑚(𝑡 = 120)  is the expression of mSpinach at time  𝑡	 = 	120	 minutes and is an approximation of 𝑚  steady state expression if the 
system were to continue to run indefinitely. The time point  𝑡	 = 	120	minutes, is critical to consider for our biomolecular breadboard system. 
Previous results generated with the TX-TL system [22, 56] suggest that protein 
production rates typically maintain as a constant within 120 minutes of the reactions. 
After 120 minutes, we can see a decrease in mRNA concentration accordingly 
(Figure 3A) as well as slower protein production (Figure 1B). Thus, an empirical 
upper bound on time horizon for our model is approximately 120 minutes after the 
reaction is initiated.  
It is also important to mention that with the exception of the mRNA species 𝑚WXY 
of NRI protein in our model, the species associated with NRI do not settle at a stable 
steady state. This aspect of our model is consistent with the behavior of biocircuit 
expression for an initial window of time in the biomolecular breadboard system. In 
this in vitro system, the auxiliary proteins NRI, K, Ph, and even GFP (expressed by 
pGlnA) do not achieve a steady state in the traditional manner (due to detailed 
balance of production, and a combination of degradation and dilution effects). Rather, 
they continue to increase in concentration until all transcriptional and translational 
resources are exhausted. Thus, because we are interested in the dynamic behavior of 
the phosphorylation-based insulator and drawing comparisons of its in vitro behavior 
to in vivo behavior, we will focus our subsequent modeling efforts in the time 
window 𝑡	Î	(0,120) minutes where fuel, energy, and other transcriptional and  
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translational resources are still abundant. In doing so, we do not preclude the 
possibility of genes competing with each other for the finite resources available in 
the in vitro system. Our time frame of interest is thus when transcriptional and 
translational machinery is available and functional, but in finite supply (mimicking 
in vivo conditions). 
Using the parameters that we have calculated, we plot the outcome of a 
simulation against expression data for mSpinach in Figure 3. The output is simulated 
with additive white noise, replicating the measurement noise present in the plate 
reader (refer to the trajectory of the negative control). We use a biocircuit expressing 
mSpinach with the constitutive promoter (pOR1-OR2 from the l regulatory operon). 
Notice that the functional form of 𝑚WXY(𝑡)  adequately describes the qualitative 
behavior of mRNA expression in the breadboard system until 𝑡	@	120 minutes. The 
rate at which mSpinach saturates is determined by the dr parameter and its steady 
Figure 3 A: Data featuring mSpinach expression on linear DNA with 100 bp 
of protection. The transcriptional unit consists of an OR1-OR2-pR promoter, 
followed by the mSpinach (no scaffold) RNA aptamer coding sequence and 
the T500 terminator. Arbitrary fluorescence units of mSpinach expression is 
plotted against time. Subtracting the background, we see that mSpinach 
expression nearly doubles as DNA concentration doubles. Past t = 120 
minutes, mSpinach expression decreases, presumably because linear DNA 
template has degraded or transcriptional resources are exhausted. Our time 
horizon of interest for the model will thus be in the interval of t Î (0, 120). 
B: Data featuring mSpinach expression driven by the OR1-OR2-pR 
promoter at 13.5 nM and 6.8 nM concentration from the time interval of 0 to 
120 minutes. mSpinach expression dynamics in the time horizon of interest 
feature a phase of steep linear growth and then saturation towards an 
asymptotic limit. C: A simulation of mSpinach expression, driven by a 
constitutive promoter at 6.8 nM and 13.5 nM DNA concentration. Notice that 
the model is able to capture the qualitative effects of mSpinach expression. 
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state value is given as 𝑘oi𝑝lg`/𝛿r . These experiments with the mSpinach RNA 
aptamer show that our model, while simple in its formulation, is sufficiently complex 
to describe transcriptional dynamics in the transcription-translation system for the 
first two hours. Thus, we will not attempt to model expression when the transcription-
translation system depletes it resources; at this point gene expression is strongly 
competitive, and production and degradation rates are largely determined by the 
available ATP, rNTPs, amino acids, etc. in the system. 
We also know that the folding rates of the GFP protein are different from those 
of NRI protein. Thus, to estimate the ratio in folding rates, we use the K-fold protein 
folding simulation software developed in [57]. Based on previous studies [58], we 
use the following equations to estimate the mRNA transcription rate and the protein 
translation rate: 
𝑑𝑚i𝑑𝑡 = 𝛼 − 𝛿𝑚i, 𝑑𝑋𝑑𝑡 = 𝜅𝑚i − 𝛾𝑋, 
where 𝑚i is the concentration of mRNA for protein 𝑋 (𝑋	 = 𝑁𝑅𝐼, 𝐺𝐹𝑃 ), 𝛼 is the 
rate of production of the mRNA for protein 	𝑋 , 𝛿 the rate of degradation of the 
mRNA, 𝜅 is the rate of translation of mRNA and 𝛾 is the rate of degradation of 
protein	𝑋. The value of 𝛼 increases with the strength of the promoter while the value 
of 𝜅 increases with the strength of the RBS [58]. Because we are using the same 
promoter and RBS for both NRI and GFP genes, they should share the same mRNA 
transcription rate and protein translation rate, despite their differences in gene length 
in first approximation. 
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We express the rates of transcription, translation, and folding for NRI in terms of 
GFP rates of transcription, translation, and folding (respectively) as follows: 
𝑘oi,W = 𝑘oi,^ ≡ 𝛼oi𝑘oi,^, 𝑘od,W = 𝑘od,^ ≡ 𝛼od𝑘od,^, 
𝑘n,W = 0.85𝑠{1.23𝑠{ 𝑘n,^ ≡ 𝛼n𝑘n,^, 
where “º” denotes a definition of 𝛼. Our model for GFP expression under the pCon 
promoter is similarly expressed as 
𝑝lg` @MN, 𝑚^C @MR, 𝐺𝐹𝑃S @T, 𝐺𝐹𝑃fgf. 
The model derived for 𝐺𝐹𝑃(𝑡) follows an analogous derivation as the model for 𝑁𝑅𝐼fgf 𝑡  . Thus, using equation 2, it is straightforward to show that 𝑁𝑅𝐼fgf 𝑡  
concentration can be expressed as 
Equation 3 
𝑁𝑅𝐼fgf 𝑡 = 𝛼oi𝑘oi,^𝛼od𝑘od,^𝛼n𝑘n,^𝑝lg`𝛿r 𝑡}2 − 1𝛿r} 𝑒[\f  = 𝛼oi𝛼od𝛼n𝐺𝐹𝑃 𝑡 . 
We see that by scaling the GFP concentration by the appropriate ratios at time 𝑡, 
we can obtain an estimate for 𝑁𝑅𝐼fgf . The above formula holds as long as the 
concentration of pCon promoter expressing GFP is the same as the concentration of 
pCon promoter expressing NRI protein with the same RBS. Otherwise, a ratio to 
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account for the scaling between the two should also be incorporated into the above 
relation. 
To summarize, we have posed a basic model for constitutive expression of NRI 
protein; the model has a closed form analytical expression that allows estimation of 
total NRI protein as a function of time. Our model relies on a basic set of chemical 
reactions describing the processes of transcription and translation. To justify our 
model at the transcriptional level, we have performed an experimental assay using 
the mSpinach RNA aptamer to ascertain the dynamics of mRNA expression in the 
biomolecular breadboard system. Our simulations and experimental data appear to 
match for up to the first two hours of the experiment, based on parameters extracted 
from various references, suggesting that our model is accurate in a time horizon of 
interest. We thus restrict our attention to this time horizon, as it represents the horizon 
in which transcription and mRNA degradation proceed unperturbed. Further, 
evidence in [37] suggests that ribosomal activity proceeds unhindered in the first two 
hours. 
We also observe that an analogous line of reasoning can be applied to estimating 𝑃ℎfgf and 𝐾fgf. We do not repeat the derivation here, as it only requires a change in 
notation. However, we emphasize that because of these observations, in the sequel 
we will refer to 𝑃ℎfgf(𝑡), 𝐾fgf(𝑡), and 𝑁𝑅𝐼fgf 𝑡  as additional input variables (so 
long as we are modeling the appropriate time horizon). Additionally, it is the ratio of 𝑃ℎfgf and 𝐾fgf that matter as a functional input in the system identification process 
and not the individual concentrations that matter. Further, it is by levering the inputs 
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model uniquely. 
2.5 Derivation of A Simplified Model for the PBI 
In this section, we derive a simplified model of the phosphorylation-based insulator 
using the chemical reaction system (equation 1). Examining the full chemical 
reaction system (equation 1), we obtain the following state space model from the law 
of mass action: 
Equation 4 
                   
WXYVf = 𝑘𝑝ℎ𝑁𝑅𝐼 ∙ 𝐾 − 𝑘𝑑𝑒𝑝ℎ𝑁𝑅𝐼𝑃𝑃ℎ 
                                         −𝑘𝑁𝑅𝐼C 𝑝^_`a + 𝑝^_`adg − 𝑘Sfg𝑁𝑅𝐼C 																							+ 𝑘S + 𝑘 f 𝑁𝑅𝐼C: 𝑝^_`a + 𝑁𝑅𝐼C: 𝑝^_`adg ,	𝑑𝑁𝑅𝐼𝑑𝑡 = 𝑘¡U𝑁𝑅𝐼C𝑃ℎ − 𝑘U𝑁𝑅𝐼 ∙ 𝐾 + 𝑘n,W𝑁𝑅𝐼S + 𝑘Sfg𝑁𝑅𝐼C,	𝑑𝑁𝑅𝐼S𝑑𝑡 = 𝑘od,W𝑚WXY,	𝑑𝑚WXY𝑑𝑡 = 𝑘oi,W𝑝WXY − 𝛿r𝑚WXY,	𝑑𝐾𝑑𝑡 = 𝑘n𝐾S,	𝑑𝐾S𝑑𝑡 = 𝑘od,L𝑚L,	𝑑𝑚L𝑑𝑡 = 𝑘oi,L𝑝L − 𝛿r𝑚L,	
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46 𝑑𝑃ℎ𝑑𝑡 = 𝑘n𝑃ℎS,	𝑑𝑃ℎS𝑑𝑡 = 𝑘od,CU𝑚CU,	𝑑𝑚CU𝑑𝑡 = 𝑘oi,CU𝑝CU − 𝛿r𝑚CU,	𝑑𝑁𝑅𝐼C: 𝑝^_`a𝑑𝑡 = 𝑘𝑁𝑅𝐼C𝑝^_`a − 𝑘S + 𝑘 f 𝑁𝑅𝐼C: 𝑝^_`a ,	𝑑𝑁𝑅𝐼C: 𝑝^_`adg𝑑𝑡 = 𝑘𝑁𝑅𝐼C𝑝^_`adg − 𝑘S + 𝑘 f 𝑁𝑅𝐼C: 𝑝^_`adg ,	𝑑𝐺𝐹𝑃𝑑𝑡 = 𝑘 f𝑁𝑅𝐼C: 𝑝^_`a, 𝑑𝑅𝐹𝑃𝑑𝑡 = 𝑘 f𝑁𝑅𝐼C: 𝑝^_`adg. 
The dimension of the state-space model is 14 and because of the presence of 
bimolecular reactions, it is nonlinear in the state of the system. Thus, it is difficult to 
obtain a closed form expression for the solution to the system. However, we will 
systematically impose a series of modeling assumptions that are physiologically 
plausible, but which greatly reduce the complexity of the model. 
First, notice that the total concentration of K, Ph, and NRI, denoted as 𝐾fgf , 𝑃ℎfgf, and 𝑁𝑅𝐼fgf, depends only on the transcription and translation reactions. Thus, 
if we consider the transcription and translation dynamics of 𝐾fgf, 𝑃ℎfgf, and 
𝑁𝑅𝐼fgf = 𝑁𝑅𝐼C + 𝑁𝑅𝐼 + 𝑁𝑅𝐼C: 𝑝^_`a + 𝑁𝑅𝐼C: 𝑝^_`adg	= 𝑘n,W𝑁𝑅𝐼S, 
in isolation, we can use the results of the previous section to obtain a closed form 
expression for their total concentration as follows: 
Chapter 2 
 
 
 
47 𝑁𝑅𝐼fgf 𝑡 = 𝑘n,W𝑘oi,W𝑘od,W𝛿r 𝑝WXY 𝑡}2 − 1𝛿r} 𝑒{[\f ,	
𝐾fgf 𝑡 = 𝑘n,L𝑘oi,L𝑘od,L𝛿r 𝑝L 𝑡}2 − 1𝛿r} 𝑒{[\f ,	
𝑃ℎfgf 𝑡 = 𝑘n,CU𝑘oi,CU𝑘od,CU𝛿r 𝑝CU 𝑡}2 − 1𝛿r} 𝑒{[\f . 
These total concentrations can be viewed as time varying parameters. If we had 
a way of quantifying the rate of transcription, translation, and folding of the 
individual proteins in the transcription-translation system, we could predictively 
estimate the trajectories of 𝑁𝑅𝐼fgf, 𝐾fgf, and 𝑃ℎfgf over time. However, we do not 
have these parameters, and thus it is advantageous to employ the previous section’s 
approach. With similar arguments, we can argue that the total concentration of these 
proteins can be expressed as the total concentration of a reporter molecule multiplied 
by a scaling constant (see equation 3). Thus, using a separate assay to quantify 
constitutive expression of a reporter molecule under a given constitutive promoter 
(and a calibration curve to convert fluorescence to molar concentration), we can use 
the reporter molecule as a proxy for estimating the true molar concentration of NRI, 
kinase or phosphatase. Therefore, we can avoid the problem of estimating 
transcriptional, translational, and folding rates of heterogeneous proteins while 
obtaining an estimate of the functional protein concentrations. Moreover, the result 
holds for all t in which RNA expression increases linearly (𝑡	£	120).  
We formalize this assumption as follows: 
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Assumption 1: We suppose that for all 𝑡	Î	[0,120] , 𝐾fgf(𝑡) , 𝑃ℎfgf(𝑡) , and 𝑁𝑅𝐼fgf(𝑡) are known parameters. This assumption thus allows us to eliminate the 
dynamics of folded kinase, unfolded kinase, folded NRI, unfolded NRI, folded 
phosphatase, unfolded phosphatase, and all mRNA dynamics. 
The remaining dynamics of the system are thus given as: 
                   
WXYVf = 𝑘𝑝ℎ𝑁𝑅𝐼 ∙ 𝐾 − 𝑘𝑑𝑒𝑝ℎ𝑁𝑅𝐼𝑃𝑃ℎ 
                                         −𝑘𝑁𝑅𝐼C 𝑝^_`a + 𝑝^_`adg − 𝑘Sfg𝑁𝑅𝐼C 
																							+ 𝑘S + 𝑘 f 𝑁𝑅𝐼C: 𝑝^_`a + 𝑁𝑅𝐼C: 𝑝^_`adg ,	𝑑𝑁𝑅𝐼𝑑𝑡 = 𝑘¡U𝑁𝑅𝐼C𝑃ℎ − 𝑘U𝑁𝑅𝐼 ∙ 𝐾 + 𝑘n,W𝑁𝑅𝐼S + 𝑘Sfg𝑁𝑅𝐼C,	𝑑𝑁𝑅𝐼C: 𝑝^_`a𝑑𝑡 = 𝑘𝑁𝑅𝐼C𝑝^_`a − 𝑘S + 𝑘 f 𝑁𝑅𝐼C: 𝑝^_`a ,	𝑑𝑁𝑅𝐼C: 𝑝^_`adg𝑑𝑡 = 𝑘𝑁𝑅𝐼C𝑝^_`adg − 𝑘S + 𝑘 f 𝑁𝑅𝐼C: 𝑝^_`adg ,	𝑑𝐺𝐹𝑃𝑑𝑡 = 𝑘 f𝑁𝑅𝐼C: 𝑝^_`a,	𝑑𝑅𝐹𝑃𝑑𝑡 = 𝑘 f𝑁𝑅𝐼C: 𝑝^_`adg. 
Next, we assume that the phosphorylation and dephosphorylation reactions occur 
at a much faster time scale than the production of GFP or RFP and the binding (and 
unbinding) reactions of NRI¥  to DNA to form (or disintegrate) activator-DNA 
complex. We justify the latter assumption through experimental observations that 
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observe phosphorylation rates on the order of 10¦	𝑚𝑖𝑛{ . Transcription factor 
binding rates are less characterized but typically binding and unbinding rates of a 
transcription factor (e.g. LacI) are 𝑂(10{)	𝑚𝑖𝑛{  and 𝑂(10)	𝑚𝑖𝑛{  
respectively [59].  
We formalize these assumptions as follows: 
Assumption 2: We suppose that 𝑘U, 𝑘¡U ≫ 𝑘S, 𝑘 f, 𝑘, 𝑘Sfg. 
Next, we suppose that the amount of DNA bound NRI¥  is smaller than the 
amount of free NRI¥  and unphosphorylated NRI and that total NRI can be 
approximated as the sum of unbound NRI¥ and NRI. Put another way, we assume 
that the molar concentration of unbound NRI protein is substantially larger than the 
molar concentration of DNA-bound NRI protein. This will certainly be the case since 
the pGlnA and pGlnAload DNA concentration will be in the nM range while the 
protein concentration of NRI will be in the µM range (refer to the arguments in the 
previous section and Figure 3). From the above reactions and assumptions, we then 
can write the dynamics of NRI¥ using the approximate conservation law  
𝑁𝑅𝐼fgf ≅ 𝑁𝑅𝐼C + 𝑁𝑅𝐼 
as follows: 
𝑑𝑁𝑅𝐼C𝑑𝑡 = 𝑘U 𝑁𝑅𝐼fgf − 𝑁𝑅𝐼C 𝐾fgf − 𝑘¡U𝑃ℎfgf𝑁𝑅𝐼C. 
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Since phosphorylation and dephosphorylation occurs at a much faster rate than 
GFP and RFP production (our ultimate time-scale of interest) and reasonably faster 
than the binding dynamics of the NRI¥ transcriptional activator, we can solve the fast 
dynamics of NRI¥ to obtain an analytical expression for the equilibrium point 𝑁𝑅𝐼¡C. 
At steady state, we have 
0 = 𝑑𝑁𝑅𝐼C𝑑𝑡 	= 𝑘U 𝑁𝑅𝐼fgf − 𝑁𝑅𝐼C 𝐾fgf − 𝑘¡U𝑃ℎfgf𝑁𝑅𝐼C, 
which implies 
𝑁𝑅𝐼¡C = 𝑘U𝑁𝑅𝐼fgf𝐾fgf𝑘U𝐾fgf + 𝑘¡U𝑃ℎfgf	
= 𝑘U𝑘¡U 𝑁𝑅𝐼fgf𝑘U𝑘¡U + 𝑃ℎfgf𝐾fgf ≡ 𝜃 𝑁𝑅𝐼fgf, 𝐾fgf, 𝑃ℎfgf , 
where “º” denotes the definition of the function 𝜃(𝑁𝑅𝐼fgf, 𝐾fgf, 𝑃ℎfgf).  
In this assumption, we also assume that 𝑘Sfg is negligible compared to other 
rates. This is a reasonable assumption since spontaneous dephosphorylation proceeds 
at a slow rate — the DG of spontaneous dephosphorylation is very large [60].  
The final assumption we leverage is that the rates of GFP and RFP production, 
relative to the binding dynamics of NRI¥ are much slower. Specifically, we suppose 
that: 
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Assumption 3: 𝑘, 𝑘S ≫ 𝑘 f. 
This assumption can be justified, since the production of a folded protein such as 
GFP takes at least ten to fifteen minutes [61] while the binding and unbinding rates 
are typically on the order of hundredths of seconds and seconds, respectively [59]. 
Thus, we can solve for the steady state of the DNA-activator complexes NRI¥: pGlnA 
and NRI¥: pGlnALoad. The result is analogous to the classical Michaelis–Menten 
model, with 𝑉r¯ = 𝑁𝑅𝐼¡C and 𝐾° 	= 	 (𝑘S 	+	𝑘 f)/𝑘. We omit the derivation, as 
it follows the standard derivation for a two-substrate one-enzyme model: 
Equation 5 
𝑑𝐺𝐹𝑃𝑑𝑡 = 𝑘 f 𝜃𝑝^_`a
fgf𝐾°1 + 𝑝^_`afgf + 𝑝^_`adgfgf𝐾° , 
𝑑𝑅𝐹𝑃𝑑𝑡 = 𝑘 f 𝜃𝑝^_`adg
fgf𝐾°1 + 𝑝^_`afgf + 𝑝^_`adgfgf𝐾° , 
where 𝜃  denotes 𝜃(𝑁𝑅𝐼fgf, 𝐾fgf, 𝑃ℎfgf) . This completes the derivation of our 
simplified model. In the next section, we will analyze the structure of the model, 
determine which of the parameters are globally identifiable, and under what 
circumstances identifiability holds.  
2.6 System Identification of the Simplified PBI Model 
A. Theoretical Analysis 
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In the derivation of our model we have made a point to retain the experimental 
parameters 𝑁𝑅𝐼fgf , 𝐾fgf , 𝑃ℎfgf , 𝑝^_`afgf   and 𝑝^_`adgfgf  . These parameters can be 
viewed as experimentally controllable, in that we can directly control the DNA 
concentration of promoters 𝑝^_`afgf   and 𝑝^_`adgfgf  . Additionally, by adjusting the 
underlying constitutive promoters driving the expression of NRI, K, and Ph we can 
effectively tune the quantities 𝑁𝑅𝐼fgf , 𝐾fgf , and 𝑃ℎfgf . We note that this type of 
control over the concentration of DNA as well as total protein concentration is not 
typically achievable in vivo, unless inducers are employed or different replication 
origins are cloned into a plasmid (which introduces variability in copy number from 
cell-to-cell). However, this advantage in the biomolecular breadboard is precisely the 
capability required to explore the problem of parameter estimation and determine if 
our simplified model is globally identifiable. 
Since our calibration curves allow us to estimate GFP concentration from 
arbitrary fluorescence units, we will focus our attention on the GFP dynamics. 
Furthermore, notice that the forms of dynamics of both reporter molecules are 
identical. Thus, it suffices to analyze the identifiability of parameters with respect to 
the output dynamics of the GFP reporter molecule, since it will yield the same result 
as studying identifiability with respect to RFP output dynamics. Recalling our 
assumptions from the previous section, we will also make a point to study the 
behavior of the system within the time horizon of interest captured by our model, 𝑡	Î	[0, tr¯) , where tr¯ is the initiation of the resource depletion phase in our 
transcription-translation system. 
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Our goal is to determine whether this model is globally structurally identifiable 
with respect to the parameters 𝐾°, 𝑘 f, 𝑘U, and 𝑘¡U, given the inputs 𝑁𝑅𝐼fgf, 𝐾fgf, 𝑃ℎfgf, 𝑝^_`afgf , and 𝑝^_`adgfgf . Notice that the inputs do not enter the dynamics 
of the system in a linear fashion. Indeed, the simplified system (equation 5) is of the 
form: 𝑑𝑥/𝑑𝑡 = 𝑓(𝑈, Θ) , where 𝑓 is nonlinear with respect to 𝑈 and Θ , in which  𝑈 = (𝑁𝑅𝐼fgf, 𝑃ℎfgf, 𝐾fgf, 𝑝^_`afgf , 𝑝^_`adgfgf ) and Θ = (𝐾°, 𝑘 f, 𝑘U, 𝑘¡U). 
Furthermore,  
𝑓(𝑈, Θ) = 𝑓(𝑈, Θ)𝑓}(𝑈}, Θ}), 
where  
𝑈 = 𝑁𝑅𝐼fgf, 𝑃ℎfgf, 𝐾fgf , Θ = 𝑘U, 𝑘¡U ,	𝑈} = 𝑝^_`afgf , 𝑝^_`adgfgf ,															Θ} = 𝐾°, 𝑘 f . 
Notice that 𝑓 = 𝑁𝑅𝐼¡C = 𝜃(𝑁𝑅𝐼fgf, 𝑃ℎfgf, 𝐾fgf)  takes the form of a Hill 
function with Phtot/Ktot as its substrate and 
𝑓} = 𝑘 f 𝑝^_`afgf𝐾°1 + 𝑝^_`afgf + 𝑝^_`adgfgf𝐾° . 
This multiplicative decomposition provides a key insight: our system dynamics 
is the product of two Hill functions with distinct inputs for each Hill function. This 
suggests that from a system identification standpoint, we can attempt a series of 
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experiments that perturb one of the Hill functions while holding the other constant 
and vice versa to tease out the parameters for each. 
To obtain insight into the what parameters in the Hill functions are identifiable, 
we invert the system dynamics to obtain 
1𝑑𝐺𝐹𝑃/𝑑𝑡 = 1𝑓𝑓} = 𝑝^_`afgf + 𝑝^_`adgfgf + 𝐾°𝜃𝑘 f𝑝^_`afgf , 
which indicates that the parameter identification is a linear regression problem, and 
after some arrangement we find that 
𝑑𝐺𝐹𝑃𝑑𝑡 𝑝^_`afgf + 𝑝^_`adgfgf𝑝^_`afgf = 𝑓𝑘 f − 𝐾° 𝑑𝐺𝐹𝑃/𝑑𝑡𝑝^_`afgf . 
Thus, when the experimental input 𝑝^_`adgfgf  is set to 0 nM, we obtain a linear 
regression problem in estimating slope 𝐾°  and intercept 𝑘 f𝑓 . Further, if we 
enforce that 𝑃ℎfgf = 0 , then 𝑓  reduces to 𝑁𝑅𝐼fgf , a known input value that 
completes the decomposition. Thus, by enforcing these two input constraints, we 
obtain a linear regression problem that effectively estimates 𝑘 f and 𝐾°. By varying 
the total DNA concentration 𝑝^_`afgf  we can thus vary the rate of change of GFP, 𝑑𝐺𝐹𝑃/𝑑𝑡 , and obtain data to optimize 𝑘 f  and 𝐾° . Once 𝑘 f  and 𝐾°  are 
estimated, we can then use a similar line of arguments to back out an estimate for the 
ratio 𝑘U/𝑘¡U. 
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In particular, we consider a nominal operating concentration of 𝑝^_`afgf   and 𝑝^_`adgfgf  , and write 𝛾 = (𝑈}, Θ})/𝑓}  and 𝑘´ = 𝑘U/𝑘¡U , then taking the 
reciprocal of 𝑑𝐺𝐹𝑃/𝑑𝑡 we obtain 
1𝑑𝐺𝐹𝑃/𝑑𝑡 = 1𝛾 (𝑘´ + 𝑃ℎfgf𝐾fgf𝑘´𝑁𝑅𝐼fgf ) 
and define 𝑌 = 𝛾𝑁𝑅𝐼fgf/(^Cf ) we see that  
𝑌 = 1 + @¶ CUIJILIJI . 
Therefore, by transforming the problem into the reciprocal space, we see that 𝑘´ = 𝑘U/𝑘¡U  is a uniquely identifiable parameter. That is, the problem of 
estimating 𝑘´  can be expressed as a linear regression problem with 𝑘´  as the 
reciprocal of the slope and an intercept of unity. The fact that we can write the 
parameter estimation problem for (𝑘 f, 𝐾°, 𝑘U/𝑘¡U) as a solution to a system of 
linear equations thus shows that the model is globally structurally identifiable with 
respect to (𝑘 f, 𝐾°, 𝑘U/𝑘¡U).  
In summary, we have derived a simplified model for the phosphorylation-based 
insulator and shown it is globally identifiable with respect to the output trajectory of 
GFP. We have shown that in the theoretical scenario where a continuous trajectory of 
GFP can be obtained to estimate its derivative 𝑑𝐺𝐹𝑃/𝑑𝑡, the parameters 𝑘 f, 𝐾°, 
and 𝑘´ = 𝑘U/𝑘¡U can be estimated. These parameters are only estimated through 
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a series of carefully designed experiments in which specific TX-TL controllable 
experimental variables are tuned. In the next section, we discuss the results of these 
experiments and numerical estimation of this data from time-series data. 
B. Experimental Analysis: Systematic Perturbations of the Phosphorylation-Based 
Insulator for System Identification 
To identify the parameters 𝑘 f , 𝐾° , and 𝑘´ , we needed to perturb the 
phosphorylation-based insulator with the experimental variables designated in our 
model. In particular, we first needed to perturb the amount of pGlnA promoter 
producing GFP in the absence of phosphatase 𝑃ℎfgf or NRIIH139N protein. Varying 
the amount of pGlnA promoter in the system in the absence of phosphatase would 
enable the estimation of 𝑘 f and 𝐾°. 
Intuitively, 𝑘 f and 𝐾° characterize the enzyme-substrate relationship that the 
activator protein NRIP has with the pGlnA promoter — coincidentally, to reveal these 
parameters we need to eliminate any negative feedback imposed on the activator 
protein by NRIIH139N phosphatase and vary the substrate concentration 𝑝^_`afgf  to 
reveal the kinetic parameters. 
Accordingly, we ran a set of TX-TL reactions in which the DNA concentration 
of pCon promoter driving NRIIH139N expression was 0 nM. We varied the 
concentration of pGlnA promoter from 0 to 57 nM, expressed on plasmid. From the 
time series data, we extracted the first thirty minutes of expression dynamics — this 
time horizon constituted the time frame when amino acids, CoA, NADH, ATP, etc. 
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were far away from the stage of complete depletion in the TX-TL system. In this time 
horizon of interest, the expression of GFP is linear with respect to time; therefore, the 
derivative of GFP is constant and can be fitted using the slope of a linear regression. 
The results of our linear regression are plotted against the time series data of the 
experiment in Supplementary Figure S3. The estimates of the 𝑑𝐺𝐹𝑃/𝑑𝑡 in the time 
horizon of interest at varying concentrations of pGlnA were used to fit the Hill 
function parameters 𝑘 f and 𝐾°: 
𝑘 f = 2.33×10{}	𝑚𝑖𝑛{,  𝐾° = 1.58	𝑛𝑀. 
We emphasize that the key to estimating 𝑘 f and 𝐾° is the additional freedom 
afforded by a control input 𝑝^_`afgf  in perturbing the system. 
The final parameter to estimate was 𝑘´ = 𝑘U/𝑘¡U. In order to estimate 𝑘´, we 
needed to fix the pGlnA concentrations, i.e. the concentrations driving expression in 
the downstream module, and perturb the phosphorylation-based insulator. 
Specifically, we varied the ratio of kinase (NRIIL16R) to phosphatase (NRIIH139N) 
in the system by varying the ratio of DNA concentrations for the promoters driving 
their expression. Doing this, we obtained a series of time-lapse curves of GFP 
expression over a range of 𝑃ℎfgf/𝐾fgf values. Again, we extracted estimates for 𝑑𝐺𝐹𝑃/𝑑𝑡 using a linear regression over the first thirty minutes of gene expression. 
The resulting estimates for 𝑑𝐺𝐹𝑃/𝑑𝑡  were then plotted against varying  𝑃ℎfgf/𝐾fgf  to fit a Hill function (Figure 4). Using standard linear regression 
techniques, we then obtained the following estimate: 
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The ratio 𝑘U/𝑘¡U characterizes the balance of rates between phosphorylation and 
dephosphorylation reactions — although we are unable to infer the individual 
parameters 𝑘U and 𝑘¡U we are able to conclude that dephosphorylation occurs at 
roughly an order of magnitude faster than phosphorylation (all other variables equal). 
Notice this parameter characterizes the intrinsic chemical reaction rates, rather than 
the flux or mass action rates that are dependent on kinase and phosphatase 
concentrations. Thus, to tune the phosphorylation-based insulator we can vary the 
amount of kinase and phosphatase concentrations, bearing in mind that 
phosphorylation is slower than dephosphorylation in the TX-TL system.  
Further, it is consistent with our intuition that only the ratio of 𝑘U and 𝑘¡U is 
identifiable and not the individual parameters. Because the individual parameters 
characterize processes that are much faster than the time-scales of production of our 
observer molecule GFP and the imaging system in the plate reader, the only 
information that can be passed onto the observer molecule is the net outcome of NRI 
protein’s phosphorylated state. Phosphorylation and dephosphorylation are processes 
that compete against each other to increase the amount of NRIP and NRI 
concentration in the system, respectively. Thus, by observing the amount of NRIP in 
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the system and knowing the concentration of 𝑁𝑅𝐼fgf, we can deduce the net outcome 
of the battle, i.e. the ratio 𝑘U/𝑘¡U. Notice that without knowledge of 𝑁𝑅𝐼fgf, we 
would be unable to estimate 𝑘U/𝑘¡U . This again illustrates the importance of 
having additional experimental inputs for perturbing the system. Even though there 
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Figure 4 Linear Regression fitting to extract parameters. A: A plot of the 
resulting Hill function 𝑑𝐺𝐹𝑃/𝑑𝑡 against varying pGlnA. We see the curve 
follows the form of a Michaelis Menten function which is consistent with 
our model. B: A plot of the resulting Hill function 	𝑑𝐺𝐹𝑃/𝑑𝑡  against 
varying 	𝑃ℎfgf/𝐾fgf .  Again, the empirical data (starred) matches the 
functional form of our model. 
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is only one output molecule GFP, we are able to infer three distinct parameters that 
represent processes from three different time-scales: catalytic synthesis of protein, 
formation and disassociation of the DNA-activator complex, and 
phosphorylation/dephosphorylation of NRI protein.  
Finally, it is worthwhile to note that the functional form of our model is consistent 
both quantitatively (small output residual error) and qualitatively. This suggests that 
our simplified model will serve as a suitable starting point for simulation studies and 
theoretical analysis. 
2.7 Simulations 
Having all the parameters identified, we first repeated the results in Figure 2 in 
simulation. As shown in Figure 5A and 5B, the control circuit suffered from the 
retroactivity when the load was added. In contrast, the insulator circuit could 
attenuate the retroactivity significantly. Both the transfer curves and the fold-change 
comparison are consistent with the experimental results.  
Then we wanted to know how would different initial conditions affect the output. 
We swept different initial conditions for the reporter pGlnA-GFP, the load pGlnA-
RFP, and phosphatase over kinase ratio (𝑃ℎfgf/𝐾fgf ) (Figure 5C and D). In  
Figure 5C, we swept [pGlnA-GFP] and [pGlnA-RFPload]. As we can see in the 
surface plot, more reporter DNA results in more GFP expression. More load DNA 
brings down the GFP level, which is a result of retroactivity as load DNA competes 
with reporter DNA for transcription and translation resources, such as RNA 
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polymerases and ribosomes. Load DNA or mRNA sequesters those resources away 
from reporter DNA or mRNA, ending up with less reporter protein made. In Figure 
5D, we changed the concentration of the load pGlnA-RFP and the ratio of 𝑃ℎfgf/𝐾fgf. As we mentioned above, when certain amounts of phosphatase and 
kinase are added, the PBI circuit will have a high gain because of phosphorylation 
and an equally large negative feedback by dephosphorylation. As a result, 
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Figure 5 Simulation results of the PBI circuit based on the parameters 
identified above. A: Simulation results of the transfer function curves for 
controls and insulators with or without load DNA are consistent with the 
experimental results. B: Simulation results of the fold changes of the samples 
without load over the ones with load are also consistent with the experimental 
results. C: Simulation results of GFP expressions as functions of two DNA 
inputs. Initial condition: DNA pGlnA-GFP ranging from 0 to 40 nM and 
DNA pGlnA-RFP (load) ranging from 0 to 40 nM, with 68 nM protein 𝑁𝑅𝐼fgf  and 𝑃ℎfgf/𝐾fgf = 0. Simulation time is 120 min. D: Simulation 
results of GFP expressions as functions of DNA load and 𝑃ℎfgf/𝐾fgf . Initial 
condition: DNA pGlnA-RFP (load) ranging from 0 to 80 nM and 𝑃ℎfgf/𝐾fgf  
varying between 0 and 1, with 20 nM DNA pGlnA-GFP and 68nM 
protein𝑁𝑅𝐼fgf . Simulation time is 120 min. 
Chapter 2 
 
 
 
62 
retroactivity from downstream load will be attenuated. The simulation results in 
Figure 5D just showed the exact same idea. By tuning the ratio, we can effectively 
achieve the same absolute GFP expression level with different absolute load amount. 
Through this mechanism, the retroactivity is largely attenuated.  
2.8 Conclusion 
In this work, we investigated the structural identifiability of the phosphorylation-
based insulator when implemented in a transcription-translation cell free expression 
system. We showed that the retroactivity exists in the TX-TL system and the PBI 
circuit can attenuate the retroactivity significantly. Then we considered a complex 
model that provided an intricate description of all chemical reactions involved in the 
PBI circuit. Next, leveraging specific physiologically plausible assumptions, we 
derived a rigorous simplified model that captures the output dynamics of the 
phosphorylation-based insulator. We performed standard system identification 
analysis and determined that the model is globally identifiable with respect to three 
critical parameters: the catalytic rate associated with the downstream system 𝑘 f, an 
internal parameter in the downstream system characterizing formation of the 
activator-DNA complex 𝐾°  and 𝑘U/𝑘¡U , and a ratio describing the intrinsic 
balance of phosphorylation and dephosphorylation in the PBI circuit. Specifically, 
we showed that these three parameters were identifiable only when the system was 
subjected to specific perturbations. We performed these experiments and estimated 
the parameters. Our experimental results suggest that the functional form of our 
simplified model is sufficient to describe reporter dynamics and enable parameter 
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estimation. Besides, our simulations results based on the parameters estimated using 
above methods confirmed our conclusions from experimental data and previous 
theoretical predictions. These in silico results also showed the power of 
computational biology and its future applications in guiding biological experiments 
and synthetic biocircuits design. In general, this research illustrates the utility of the 
TX-TL cell free expression system as a platform for system identification, as it 
provides extra control inputs for parameter estimation that typically are unavailable 
in vivo. Future work will investigate the theoretical utility of the TX-TL system as a 
platform for system identification, parameterization of more complex systems, and 
the robustness and sensitivity of the phosphorylation-based insulator using our 
derived model.  
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Materials and Methods 
Plasmids and linear DNAs: 
DNA and oligonucleotides primers were ordered from Integrated DNA Technologies 
(IDT, Coralville, Iowa). Plasmids in this study were designed in Geneious 8 
(Biomatters, Ltd.) and were made using standard golden gate assembly (GGA) 
protocols and maintained in a KL740 strain if using an OR2- OR1 promoter (29°C) 
or a JM109 strain for all other constructs. Plasmids were mini prepped using Qiagen 
mini prep kit. BsaI-HF (R3535S) enzyme used in GGA was purchase from New 
England Biolabs (NEB). Linear DNAs were made by PCRing protein expression 
related sequences out of GGA constructs using Phusion Hot Start Flex 2X Master 
Mix (M0536L) from NEB. Rapid assembly procedures were based on [22]. Before 
being used in the cell-free reaction, both plasmids and PCR products underwent an 
additional PCR purification step using a QiaQuick column (Qiagen), which removed 
excess salt. Then PCR products were eluted and stored in deionized water at 4°C for 
short-term storage and −20°C for long-term storage. All the plasmids used in the 
work can be found on https://www.addgene.org/. 
Fluorescent proteins: 
Two fluorescent proteins were used in this work, GFP and RFP.  The version of GFP 
used is deGFP, which is also called eGFP-Del6-229 [62]. The RFP used is mCherry 
[63]. 
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TX-TL reactions and fluorescence measurements: 
TX-TL reaction mix was prepared and set up according to previous JOVE paper [21]. 
TX-TL reactions were conducted in a volume of 10 µL in a 384-well plate (Nunc) at 
29°C, using a three-tube system: extract, buffer, and DNA. For deGFP, samples were 
read in a Synergy H1 plate reader (Biotek) using settings for excitation/emission:  
485 nm/525 nm, gain 61. All samples were read in the same plate reader, and for 
deGFP relative fluorescence units (RFUs) were converted to nM of protein using a 
purified deGFP-His6 standard. Unless otherwise stated, end point measurements are 
after 2 h of expression at 29°C. 
Computational models and simulations: 
Data analysis and fitting, model building, and simulations were conducted in 
MATLAB (R2015b, The MathWorks, Inc.) software.  
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Supplementary Materials 
Supplementary Figures 
 
Supplementary Figure S1 Demonstration of the phosphorylation 
cycle in TX-TL. Before testing the insulation capability of this circuit, 
we need to demonstrate that phosphorylation and dephosphorylation 
work in TX-TL. A: While keeping the phosphatase at 0 and 
increasing the concentrations of kinase NRIIL16R linear DNAs, we 
observed higher pGlnA-deGFP expression as a result of more NRIP. 
B: When we kept the kinase concentration constant and increased the 
concentrations of NRIIH139N linear DNAs (higher Ph/K ratio), less 
pGlnA-deGFP was expressed as a result of dephosphorylation of 
NRIP. These results suggested that the phosphorylation cycle worked 
in TX-TL system. C: We also found that σ54 DNA was needed as 
there was little to no σ54 in the TX-TL cell extract, which is required 
for the σ54-dependent promoter pGlnA to work. While keeping 
kinase, phosphatase, and pGlnA-deGFP constant, adding more σ54 
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DNA significantly increases the expression of deGFP. D: We also 
found that additional phosphate source was recommended but not 
essential; as shown in the panel, increasing carbamoyl phosphate 
concentrations did not significantly affect the expression of deGFP. 
All the deGFP fluorescences have been converted to nM using 
purified deGFP calibration data. 
 
Supplementary Figure S2 Test the temperature sensitivity of the 
PBI circuit at three different temperatures, 29°C, 33°C, and 37°C. A, 
B, C: Transfer function curves for controls and insulators with or 
without load DNA at three different temperatures. 
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Supplementary Figure S3 GFP expression kinetics were used to 
estimate the GFP production rate. A: Plot of GFP expression while 
varying the 𝑃ℎ/𝐾 ratio. Curves from t = 0 to tr¯	 = 	30 min were 
used to estimate the slope of GFP. B: Expression dynamics of GFP 
for varying amounts of pGlnA with 𝑝𝐿𝑎𝑐 − 𝑃ℎ	 = 	0	𝑛𝑀 . These 
curves enable the estimation of 𝑑𝐺𝐹𝑃/𝑑𝑡 for 𝑡	£	tr¯ = 	30	𝑚𝑖𝑛. 
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Brief introduction on retroactivity and how to attenuate it 
A grand challenge in utilizing modular biological circuits is how to efficiently and 
robustly connect different modules to yield more complex systems. A difficulty that 
arises upon the interconnection of two modules in series is a phenomenon called 
retroactivity [43, 64]. Even if one of the modules is designed to be upstream or 
driving the input of the second module, a load from the downstream/second module 
is generated upon interconnection of the two modules that alters the internal 
dynamics of the first module. There have been significant discoveries on the subject 
of retroactivity. In [43], the authors developed a rigorous mathematical definition for 
describing and quantifying retroactivity between two modules. In [65], formal 
expressions for intramodular and intermodular retroactivity are derived for complex 
gene transcription networks consisting of nodes, modules, and systems. Additionally, 
the authors in [66] show that long signal cascades can attenuate retroactivity, while 
[67] utilizes a time-scale separation strategy to attenuate retroactivity. Finally, in [68] 
the authors show that attenuating retroactivity can have the unwanted effect of 
amplifying high frequency noise in gene expression. 
An insulator is a biocircuit designed to insulate two biocircuit modules connected 
in series from the effects of retroactivity. An upstream module 𝑆 has input 𝑢 and 
output 𝑦  while the downstream module 𝑆}  has input 𝑢}  and output 𝑦} 
(Supplementary Figure S3). In a system free of retroactivity effects, the signal  𝑢} = 𝑦  and there is no signal that maps from 𝑆}  to 𝑆 . However, in biological 
systems, the output of a system is often a molecule that is consumed or incorporated 
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in a downstream process. In terms of our model, once 𝑆} is interconnected to 𝑆, a 
retroactive input r from 𝑆} to 𝑆 that modifies the dynamics of the output 𝑦 must be 
incorporated in our model. The variable 𝑟 is referred to as retroactivity to the output 𝑦 and also retroactivity to the input 𝑢}. A general framework is derived in [68] to 
describe arbitrary systems, but for our analysis of the phosphorylation-based 
insulator, we will suppose in the native or uninsulated system we have two modules 𝑆 and 𝑆} where the dynamics 𝑆 are given as: 
¯»f = 𝑓 𝑥, 𝑢, 𝑟 ,   𝑦 = 𝑌 𝑥, 𝑢, 𝑟 , 
and the dynamics of 𝑆} are given as 
 
Supplementary Figure S4 A schematic illustrating the structure and 
function of the phosphorylation-based insulator. In a natural uninsulated 
setting, upon interconnection of an upstream system (𝑆) and downstream 
system (𝑆}), a “retroactivity signal” comes into existence that may alter 
the dynamics of the upstream system. However, by inserting an insulating 
device between the two, retroactivity to the upstream system is abolished 
and the insulating device is tuned to minimize the impact of retroactivity 
on its own internal dynamics. 
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Notice that due to the nature of interconnections in biology, the states 𝑥 of 𝑆 may 
have overlap with the inputs 𝑢} of 𝑆}. In particular, even though 𝑦 may also be a 
state in 𝑆, 𝑦 = 𝑢} is the input for 𝑆}. Additionally, we will consider systems 𝑆 and 𝑆} to be interconnected only to each other. Thus, those familiar with the work of [68] 
will note that we have omitted the retroactivity to the input signal for 𝑆 and the 
retroactivity to the output signal of 𝑆}. The retroactivity signal we wish to center our 
attention on is 𝑟, which describes the retroactivity to the output signal for 𝑆 , or 
viewed from the perspective of 𝑆}, the retroactivity to the input signal for 𝑆}. 
The purpose of the phosphorylation-based insulator is to insulate systems 𝑆 and 𝑆}  from the retroactivity effects that arise from their interconnection. 
Mathematically, the insulator can be considered as a separate system 𝑆Y  with the 
express purpose of eliminating retroactivity to the output 𝑦  (and equivalently 
retroactivity to the input 𝑢}). In the literature, the insulator is inserted as a separate 
system in between 𝑆  and 𝑆}  — we will adopt the same paradigm. Thus, the 
dynamics of the insulated system are given as 
¯»f = 𝑓 𝑥, 𝑢 ,   𝑦 = 𝑌 𝑥, 𝑢 , 
and the dynamics of 𝑆Y (denoted 𝑆Y` in Figure S3) are given as 
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Notice the former retroactivity of the input 𝑢}, referred to as 𝑟, acts as a retroactivity 
to the output of the insulator module 𝑆Y . At the same time, notice that the system 
dynamics of 𝑆Y are such that the upstream system 𝑆 is insulated from the effects of 𝑟; that is, no retroactivity signal maps from the insulator to 𝑆 . In this way, the 
dynamics of 𝑆Y are structured to insulate the upstream module 𝑆 from the effects of 
the downstream module 𝑆}. 
The key to attenuating the retroactivity 𝑟 is a design strategy of high gain coupled 
with negative feedback. This principle is borrowed from the design of electronic 
amplifiers, where retroactivity is made negligible by a theoretically infinite 
amplification gain and equally large negative feedback gain. This principle can be 
motivated using a simple linear systems model. Consider the output function 𝑌Y of 
the insulator 𝑆Y , and suppose that 𝑟  enters as an additive disturbance in 𝑌Y . We 
suppose that negative feedback is implemented on the output 𝑦Y with gain 𝐾 and that 𝐺 is a transfer function describing the insulator 𝑆Y. Then supposing we can write the 
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closed loop (insulator) dynamics of 𝑦Y in the Laplace domain, we have the following 
expression from [68]: 
𝑦Y 𝑠 = 𝐺 𝑠 𝑢Y 𝑠 − 𝐾 𝑠 𝑦Y 𝑠 + 𝑟Y 𝑠 , 
which can be written as 
𝑦Y 𝑠 = 𝐺(𝑠)1 + 𝐾 𝑠 𝐺(𝑠) 𝑢Y 𝑠 + 11 + 𝐾 𝑠 𝐺(𝑠) 𝑟Y 𝑠 . 
By increasing the gain of either 𝐺 or negative feedback gain 𝐾, we can render the 
contribution from the retroactivity 𝑟 negligible. Finally, as we increase the system 
gain of 𝑆Y , namely the gain of 𝐺, the signal 𝑦Y 𝑠  tends towards 𝑢Y 𝑠 /𝐾. So far, 
these observations only impose high-level design specifications on the 
phosphorylation based insulator. In [68], these design specifications are shown to be 
satisfied by two types of insulators: a transcriptional feedback insulator and a 
phosphorylation-based insulator. Our paper focuses on modeling and 
characterization of the latter in the TXTL system. 
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C h a p t e r  3  
EXPRESSING BIOLOGICALLY ACTIVE MEMBRANE PROTEINS IN A 
CELL-FREE TRANSCRIPTION-TRANSLATION PLATFORM 
Abstract: 
Cell-free transcription-translation platforms have been shown to be essential in basic 
synthetic biological circuit prototyping. From the synthetic biology’s point of view, 
the ability to use membrane proteins in biocircuits in cell-free transcription-
translation systems is critical, considering the fact that histidine kinases, G-protein 
coupled receptors (GPCRs) and other important biosensors are all membrane 
proteins. Previous studies have expressed membrane proteins in cell-free systems 
with the help of detergents, liposomes, or nanodiscs, but have not demonstrated the 
ability to prototype circuit behavior for the purpose of testing more complex circuit 
functions involving membrane-bound proteins. Built on previous efforts, in this work 
we demonstrated that we could co-translationally express soluble and active 
membrane proteins in our cell-free TX-TL platform with membrane-like materials. 
We first tested the expression of several constructs with β1 and β2 adrenergic 
receptors in TX-TL and observed significant insoluble membrane protein production. 
And with the addition of lipoprotein-based membrane-like material – nanodiscs, we 
were able to make soluble and active membrane proteins which exhibited positive 
binding to their ligands carazolol and norepinephrine via both fluorescence assay and 
Surface Plasmon Resonance (SPR) binding assay. Our results suggest that it is 
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feasible to use cell-free systems to prototype synthetic biocircuits involving single 
chain membrane proteins without extra procedures, leading us one step closer to 
testing complex membrane protein circuits in cell-free environment.  
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3.1 Introduction 
Cell-free transcription-translation systems have shown to be extremely useful in 
synthetic biological circuit prototyping [23, 24]. Typical cell-free transcription-
translation systems are based on S30 E. coli extract [38] and there have been many 
different versions. The specific version used in this paper referred to as “TX-TL”, 
has been optimized for prototyping synthetic biocircuits [20, 21]. Unlike other cell-
free protein expression systems, including the PURE system, which are based on 
bacteriophage transcription by supplementing bacteriophage RNA polymerases to 
the crude cytoplasmic extracts [69], TX-TL has been shown to be suitable for 
complex biochemical systems [20, 22-24]. 
Membrane proteins are of great importance for proper functioning cells and 
organisms. They lay the foundation for many biosensors and signal pathways in  
cells [70]. Some membrane proteins act as ion channels to transport ions across 
membranes [71]; others make up the essential parts of sensory system which are 
responsible for cell communication [72], while membrane enzymes catalyze 
important chemical reactions near membranes [73]. In addition, membrane proteins 
are the most important drug targets, for example more than half of therapeutics for 
treatment of various modalities ranging from cancer to cardiovascular diseases target 
membrane proteins [74]. 
Membrane proteins are difficult targets as compared to soluble proteins because 
of the challenges associated with their expression, solubilization, and stabilization. 
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Typical studies of membrane proteins rely on proteins produced from cells and 
solubilized cell membrane using detergents, liposomes, or other membrane-like 
materials. Although this approach may have advantages in terms of protein yield, it 
is not well-suited for high-throughput assays since for each construct transformation, 
cell growth, lysis, membrane solubilization, and purification are involved [75]. 
Furthermore, these techniques are not suitable for biocircuits prototyping either 
because the membrane proteins have to be in functional conformations right after 
expression for the circuits to work without further solubilization or purification 
processes. As a result, the best way to approach it would be to express membrane 
proteins in vitro in presence of a membrane-like material. There have been several 
studies on using detergents, liposomes, or nanodiscs to help solubilize and stabilize 
membrane proteins generated in cell free system [75-81], but there are limitations of 
these methods in translating results to circuit prototyping in TX-TL. 
Here, we demonstrated that membrane proteins can be directly integrated into 
future synthetic biocircuits for performing more complex functions (an additional 
study on a potassium channel membrane protein can be found in Supplementary 
Materials “Expressing a chimera potassium channel membrane protein KcsA-Kv1.3 
in TX-TL”).  Among all the important membrane proteins, we picked G protein 
coupled receptors (GPCRs), β2 (and β1) adrenergic receptors (β2AR/ β1AR) as 
model proteins [82, 83]. With more than 900 members, GPCRs are one of the most 
important and the largest integral membrane proteins family in human cells and the 
most important clinical drug targets as they play important roles in many 
Chapter 3 
 
 
 
78 
physiological functions and implicated in many diseases [84, 85]. GPCRs all share 
the same topology – seven transmembrane a-helices, and they are thought to function 
in monomeric form [86], although there have been studies indicating their 
dimerization [87, 88]. We used TX-TL platform in combination with nanodisc for 
expressing β2AR/β1AR and subsequent in situ stabilization (Figure 1A). 
Furthermore, biological activity of these proteins was confirmed by testing their 
bindings to the ligands. 
3.2 Results and Discussion 
We ordered gene synthesis services and then used golden gate assembly [89] to make 
three different GPCR constructs with three different variants, which share the same 
backbone, promoter, ribosome binding site, and terminator (Figure 1B); Table 1 lists 
the difference in coding sequences corresponding to various adrenergic receptor 
constructs. All three constructs also shared the same superfolder GFP (sfGFP) fusion 
protein topology, which was tagged with 6xHis tag at the C-terminal of the protein. 
sfGFP is used for monitoring and quick estimation of target protein expression level 
GPCR%Protein Construct Protein%Size
β1#AR#ts:)3ZPR)Thermostabilized)turkey)β1)adrenergic)receptor pSG73:)protein#sfGFP#His6 65kD)(35kD)minus)sfGFP)
β2#AR)wild)type:)ADRB2_HUMAN)β2)adrenergic)receptor pSG74:)protein#sfGFP#His6 75kD)(45kD)minus)sfGFP)
β2#AR#T4L:)2RH1)β2#adrenergic)receptor/T4#lysozyme)chimera pSG75:)protein#sfGFP#His6 85kD)(55kD)minus)sfGFP)
Table 1 Information of GPCR constructs used in experiments. pSG73 and 
pSG75 have the corresponding PDB number noted. Protein size of each 
fusion protein is also listed. 
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during and at the end of TX-TL. Whereas, 6xHis tag was used to detect proteins in 
Western, to capture the protein for binding assays, and for affinity purification, if 
necessary.  
One of the advantages of TX-TL expression platform is that we can use either 
linear DNA or plasmid DNA for expression in TX-TL [22]. Because of that, we can 
S30	E.	coli
cell	extract
Buffer:
Amino	acids
Energy	solutions
TX-TL	reaction
1
2
Protein	aggregates
Nanodisc-solubilized	proteins	
GPCR sfGFP(6xHis
Promoter RBS Terminator
+
A
B
Figure 1 Illustration of the TX-TL experimental setup and a plasmid map of the 
constructs. A: A simplified illustration of the TX-TL experimental setup with 
DNAs, cell extracts and buffers. TX-TL reactions designed for membrane protein 
expression can yield two different outcomes: 1) protein aggregates without any 
membrane-like materials; 2) nanodisc-solubilized proteins when nanodiscs are 
added. B: Circular plasmid map of pSG74. pSG74 and pSG75 share the same 
features as pSG73. 
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implement fast construct prototyping in TX-TL by ligating parts together and 
amplifying the linear DNAs with PCR, avoiding cloning the linear fragments into 
plasmid. To express these constructs in TX-TL, we simply add linear DNAs of these 
constructs to TX-TL reaction mixes. The iteration of each prototyping test using 
linear DNAs in TX-TL can take as less as 12 hours, much faster compared to 
traditional approaches, which can take around days to weeks for one iteration. 
We first estimated the expression level of pSG73-75 in TX-TL by measuring the 
fluorescence of sfGFP which was fused at the C-terminal of β2AR or β1AR, using a 
plate reader at 485 nm (absorbance)/525 nm (emission). All the linear DNA 
constructs showed a GFP fluorescence signal, indicating successful expression of the 
fusion proteins in TX-TL (Figure 2A). Different constructs, despite having exactly 
the same promoter, ribosome binding site, fusion protein framework, and DNA 
concentration, showed different expression levels of sfGFP, especially pSG74. This 
suggested that the difference in coding sequences could affect transcription and 
translation level (detailed descriptions of “The trials and errors of the expressions of 
β1AR/ β2AR proteins in TX-TL” can be found in Supplementary Materials. Another 
observation was that increasing linear DNA concentration could help increase the 
fusion protein expression, but this increase was limited by TX-TL resources and/or 
toxics accumulated in batch mode, as shown elsewhere [37]. Setting up TX-TL 
reactions in dialysis systems is likely to improve the protein expression level.  
After testing the fusion protein expression level, we explored the possibility of 
stabilizing hydrophobic membrane protein by providing a membrane mimic into the 
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reaction. Detergent micelles, liposomes, and nanodiscs are commonly used to 
provide a hydrophobic environment to membrane proteins [90]. We observed that 
the majority of detergents were detrimental to the TX-TL reaction comprising 
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Figure 2 Expression of pSG73-75 constructs in TX-TL measured by GFP 
fluorescence. A: End point measurement of GFP expression from 10nM, 20nM and 
40nM linear DNA of pSG73, pSG74 and pSG75 in 10µL TX-TL. B: End point 
measurement of GFP expression from 20nM linear DNA of pSG73-75 with or without 
24µM nanodiscs in TX-TL. ND1 is MSP1D1-DMPC and ND3 is MSP1E3D1-DMPG. 
Measurements were done at 29°C in BIOTEK Synergy H1 Hybrid Multi-Mode 
Microplate Reader using ex485nm/em525nm. 
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membrane proteins (Supplementary Figure S1). Conversely, reconstituting protein 
into the liposome resulted in a poor yield of the folded protein, which could be 
attributed to the liposome’s closed topography. Therefore, we employed a nanodisc, 
a lipid-protein complex composed of lipids constrained by a membrane scaffold 
protein (MSP). The nanodisc provides a robust platform with two-dimensional 
topography for reconstituting TX-TL expressed membrane protein. We chose two of 
the most commonly used nanodiscs: MSP1D1-DMPC (ND1) ~10nm diameter, and 
a slightly larger version MSP1E3D1-DMPG (ND3) ~13nm in diameter [75, 91].  
We repeated the TX-TL expression experiment in the presence/absence of ND1 
or ND3. As shown in Figure 2B, the presence of the nanodisc improves the TX-TL 
efficiency, as indicated by enhanced GFP fluorescence. The nanodisc does not have 
any intrinsic fluorescence, and therefore the increased fluorescence should be arising 
from the fusion protein. GPCR-sfGFP fusion protein precipitated in the TXTL 
reaction mix without nanodisc. However, in the presence of nanodisc, the supernatant 
of the reaction mixture exhibited increased GFP fluorescence signal, indicating that 
nanodiscs likely help stabilize fusion membrane proteins in TX-TL, and keep the 
folded fusion protein in supernatant. 
To further confirm that the target fusion proteins were expressed in TX-TL and 
nanodiscs could help solubilize GPCR-sfGFP fusion proteins, we ran SDS-PAGE of 
TX-TL samples and western blots with an anti-His6 antibody. First, we ran the whole 
reaction samples of three different constructs at three different concentrations  
(Figure 3A). As illustrated on the blot, samples that had one of the three constructs 
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showed significant detection of His-tagged proteins, and protein size was confirmed 
on the blot using a ladder. In contrast, the negative control sample without DNA had 
no His-tagged signal. Additionally, there were not significant differences between 
different concentrations in pSG73 and pSG75, suggesting mass-transfer nutrients 
limitation and toxic accumulation in the TX-TL reaction as discussed earlier. Another 
interesting observation was that pSG73-β1AR-ts did not show dimerization but 
pSG74 and pSG75, which were both β2AR based fusion proteins, showed strong 
dimer bands on the blot. The presence of GPCR dimerization is consistent with 
previous reports [88, 92]. 
Monomer
Dimer
No*DNA pSG73:*β14AR4ts
10nM 20nM 40nM 10nM 20nM 40nM 10nM 20nM 40nM
pSG74:*β24AR pSG75:*β24AR4T4L
Monomer
Dimer
pSG73:*β14AR4ts pSG74:*β24AR pSG75:*β24AR4T4L
Nanodisc ! ND1%%%%%ND3 ! ND1%%%%%ND3 ! ND1%%%%%ND3
A
B
Figure 3 Western blots of TX-TL reactions. A: Results of whole reaction TX-TL 
samples. After measuring the fluorescence of the TX-TL reaction, they were used 
for western blot using the method in Materials and Methods. TX-TL reaction with 
no DNA was used as negative control and three different concentrations of three 
different constructs were run under the same condition. B: Results of only 
supernatant from TX-TL samples. Only soluble samples were run on this blot. 
Supernatants without any nanodiscs were run at the same condition as ones with 
either ND1 or ND3. Full gels can be found in Supplementary Figures S7 and S9 in 
“The trials and errors of the expressions of β1AR/ β2AR proteins in TX-TL”. 
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We further tested the presence of ND by spinning down the TX-TL reaction mix 
and took supernatant only to run the western blot. All the insoluble proteins would 
precipitate out and ended up in the pellet after centrifugation. Only soluble proteins 
would be in the supernatant and can be detected in the western blot. In Figure 3B, we 
had three different constructs and each of them had three different experimental 
conditions: no nanodisc, with ND1 (MSP1D1-DMPC), and with ND3 (MSP1E3D1-
DMPG). All target proteins generated in TX-TL precipitated without nanodiscs and 
left in the pellet (confirmed by running pellet on western blot, data not shown). On 
the contrary, when either ND1 or ND3 was added into the reaction, we saw 
significant bands of target membrane proteins by the Western, suggesting that these 
hydrophobic membrane proteins became soluble with help from nanodiscs.  
So far, we have demonstrated that target membrane proteins produced in TX-TL 
reactions can be solubilized and stabilized with the in situ presence of nanodiscs. 
However, protein association with the nanodisc does not insure that these proteins 
are biologically active. To further test whether these soluble proteins were active, we 
designed two binding assays: fluorescence-based carazolol binding assay and surface 
plasmon resonance (SPR) based norepinephrine binding assay. 
Although there is no need to purify the protein for circuit prototyping, purification 
is required to confirm the binding activity of TX-TL expressed protein to avoid 
interference caused by E. coli endogenous proteins in the TX-TL reaction mix. We 
use Ni-NTA affinity chromatography to purify His-tagged target protein. 
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Fluorescence-based carazolol binding assay uses (S)-carazolol, a derivative of 
the potent β blocker carazolol with fluorescence properties  
(ex633nm/em650nm) [93]. This ligand can be used as a fluorescence tracker for 
β2AR binding activity. The detailed experimental setup is described in Materials and 
Methods. Briefly, purified membrane proteins were incubated with or without 
carazolol for one hour. These samples were further dialyzed against 100X volume 
buffer overnight. Subsequently, all the samples were concentrated down to their 
starting volume and fluorescence signal was measured in a plate reader. Green 
fluorescence (GFP) indicates the amount of fusion proteins in the samples and red 
fluorescence represents the amount of carazolol bound to target membrane proteins 
as an indication of protein activity. We used two different ND1 (MSP1D1-DMPC) 
in this assay: 1) HisND uses 6xHis tagged MSP1D1 and was purchased from Cube 
Biotech; 2) BiotinND uses biotinylated MSP1D1 and was made in house.  
Results from fluorescence binding assays showed that there was not much 
difference in the green fluorescence signal between the samples (Supplementary  
Figure S2). To simplify the data, we normalized the fold change of carazolol red 
fluorescence using the fold change of GFP fluorescence to calculate the relative 
carazolol bound to each GPCR-sfGFP protein (Figure 4A). As we can see in  
Figure 4B, we observed significant associations of carazolol to every fluorescence 
unit of GPCR-sfGFP protein. We attribute the higher carazolol signal on HisND 
reconstituted GPCR to the presence of empty ND after Ni-NTA affinity 
chromatography purification.  
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One limitation of fluorescence-based assay is that non-specific binding of 
carazolol to lipids surrounding membrane protein could cause higher signal-to-noise 
ratio. To overcome this, we developed a SPR-based binding assay using 
norepinephrine, which is a partial agonist for β2AR. Since norepinephrine shares the 
same binding pocket with carazolol [94], we tethered norepinephrine to the surface 
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Figure 4 Binding assays of TX-TL made β1 and β2 adrenergic receptor. A: Illustration 
of how we calculated the fold change of carazolol red fluorescence. The number was 
the ratio of red fluorescence signal from β1 and β2 adrenergic receptor samples 
incubated with carazolol to the ones without carazolol. A detailed experimental method 
is in Materials and Methods. All samples were dialyzed against buffer without 
carazolol overnight to remove non-binding carazolol. The exact same method was also 
used to calculate fold change of GFP fluorescence. B: Bar chart of the fold change of 
carazolol red fluorescence normalized with GFP fluorescence from the same samples. 
The number was calculated by dividing the fold change of carazolol red fluorescence 
by the fold change of GFP fluorescence. What we have here essentially indicates how 
much carazolol is associated with each GPCR-sfGFP protein. C: Response curves of 
β2 adrenergic receptor proteins binding to SPR surface coated with norepinephrine. 
Red curve is the response signal from β2-AR sample without carazolol. Green curve is 
the response signal from sample incubated with 1µM carazolol. The bottom curves are 
the corresponding control channels. D: Bar chart of the end point of the response curves 
in C. 
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via amide bond between its primary amine and the carboxyl group on the surface. 
We hypothesized that carazolol could be used as a competitor for β2AR to 
norepinephrine binding on SPR. As shown in Figure 4C, SPR binding response of 
β2AR decreased to ~60% when it was incubated with 1µM carazolol, indicating 
specific interaction between β2AR and its binding partners.  
To summarize, we have demonstrated that 1) membrane protein can be expressed 
in TX-TL at analytical scale; 2) presence of nanodisc during TX-TL reaction 
facilitates folding and solubilization of single chain membrane protein; 3) 
fluorescence and SPR binding assays were developed to demonstrate specific 
interaction between small-molecule and nanodisc-stabilized membrane protein.  
3.3 Conclusions 
In this work, we tested proteins from the GPCR family in our cell-free transcription-
translation (TX-TL) system, which would be ideal for synthetic biocircuit 
prototyping. We expressed β1AR/ β2AR in TX-TL with nanodiscs and were able to 
show that not only these membrane proteins are soluble in TX-TL with nanodiscs, 
but they were also active. Nanodiscs are co-translationally associated with membrane 
proteins without extra processing, which enables one pot prototyping in TX-TL for 
testing a complete biocircuit with membrane protein of interest involved.  
We intend to optimize our binding assays and perform competitive binding 
experiments to test the stringency of this assay. We envision that GPCR co-expressed 
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with G protein can be expressed by TX-TL to test the biological circuit including 
signal transduction.  
Additionally, histidine kinases, which phosphorylate corresponding response 
regulators, can activate downstream transcription and translation. We have started 
tested some hybrid histidine kinases and have seen promising results. Our goal is to 
prototype a logic biocircuit with membrane enzyme in it, expanding TX-TL platform 
to broader topics.  
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Materials and Methods: 
Plasmids and linear DNAs: 
DNA and oligonucleotides primers were ordered from Integrated DNA Technologies 
(IDT, Coralville, Iowa). Plasmids in this study were designed in Geneious 8 
(Biomatters, Ltd.) and were made using standard golden gate assembly (GGA) 
protocols. BsaI-HF (R3535S) enzyme used in GGA was purchase from New England 
Biolabs (NEB). Linear DNAs were made by PCRing protein expression related 
sequences out of GGA constructs using Phusion Hot Start Flex 2X Master Mix 
(M0536L) from NEB.  
TX-TL reactions: 
TX-TL reaction mix was set up according to previous JOVE paper [21]. Briefly, TX-
TL extract and buffer were mixed together with calculated linear DNAs or plasmids 
with or without nanodiscs. Reaction volumes varied from 10µL (initial screening) to 
1mL (protein purification and analysis). 
Gel and western blot: 
Gels used in this work were Bolt 4–12% Bis-Tris Plus Gels from ThermoFisher 
Scientific. Running buffer was Bolt MES SDS Running Buffer. Gels were run 
without reducing agents. Protein samples were mixed with LDS sample buffer before 
loading into gels. iBlot 2 Gel Transfer Device and iBlot Nitrocellulose Regular 
Stacks were used for transfer proteins from gel to membrane. Membrane was then 
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transferred to iBind device and incubated with Penta-His HRP Conjugate in 1:500 
dilutions. Blots were detected using SuperSignal Chemiluminescent HRP Substrates 
from ThermoFisher Scientific. 
Protein purification: 
TX-TL reaction mix was first spun @14,000g for 10min at 4°C. Supernatant was 
then transferred to buffer-equilibrated HisPur Ni-NTA Spin Purification column 
(ThermoFisher Scientific) and incubated with shaking for 1h, and then spun down 
the flow through @2000g for 2min and washed with nanodisc buffer (20 mM Tris  
pH 7.4, 0.1 M NaCl) added with 20mM imidazole three times. Elution was done by 
adding elution buffer (20 mM Tris pH 7.4, 0.1 M NaCl, 250mM imidazole) for three 
times 2 column volume. Proteins were then concentrated using Amicon Ultra 
Centrifugal Filter Units (Millipore) with Ultracel-30 membrane. 
Fluorescence-based carazolol binding assay: 
Carazolol was purchased from Abcam (S)-Carazolol Fluorescent ligand (Red) 
ab118171. Each purified protein was first divided into two equal volume samples. To 
one was added 100nM carazolol (dissolved in water) and to the other was added the 
same volume of water. They were incubated at 4°C for 1h before being transferred 
to mini 10k MW D-Tube Dialyzers (Millipore) and dialyzed against 100x volume of 
nanodisc buffer for overnight. Then dialyzed samples were concentrated using 
Amicon Ultra Centrifugal Filter Units (Millipore) with Ultracel-30 membrane to the 
starting volume. Samples were then put into a Biotek synergy H1 hybrid multi-mode 
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microplate reader and measured for GFP fluorescence (ex485nm/em525nm) with 
gain 61 or gain 100 or Red fluorescence (ex633nm/650nm) with optimal gain. GFP 
fluorescence was converted to nM using calibration data from purified GFP protein. 
Surface Plasmon Resonance (SPR) based norepinephrine binding assay: 
GE Biacore T-200 SPR system was used for SPR experiment. Gold plated chip was 
first immobilized with norepinephrine and then washed away extra chemical. The 
equilibrating buffer and running buffer were both the nanodisc buffer. There were 
four channels on one chip. Two were used as experimental channels and the 
remaining two were used as negative controls to provide background response from 
buffer. One sample was incubated with 1µM carazolol for 1h at to test binding 
specificity and the other sample was incubated with same volume of water. Samples 
were then loaded and flowed through corresponding experimental channels and 
response curves were recorded.  
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Supplementary Materials 
Supplementary Figures 
 
Supplementary Figure S1 Bar chart showing the impact of 
various detergents on the expression of GFP in TX-TL. All 
samples had 10 nM of pCon-GFP DNA in it. Except for the 
positive control sample, reactions were added with the 
detergents marked under the bars. For detergents FC12 
(dodecylphosphocholine), DM (n-decyl-β-D-maltoside), NG (n-
nonyl-β-D-glucoside), DG (n-decyl-β-D-glucoside) and 
CHAPS, 2X of the critical micelle concentration (CMC) was 
used. For detergents LMPG, DDM (n-dodecyl-β-D-maltoside), 
and LDAO (lauryldimethylamine N-oxide), 5X of CMC was 
used. For Brij 35 and Brij 58, 10X CMC was used. 
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Supplementary Figure S2 A: Bar chart of carazolol 
fluorescence fold change. The fold change is the ratio of red 
fluorescence signal from samples incubated with carazolol to the 
ones without carazolol. A detailed experimental method is 
described in Materials and Methods. All samples were dialyzed 
against buffer without carazolol to remove non- binding 
carazolol. B: Bar chart of GFP fluorescence fold change with the 
same samples from A. The fold change is the ratio of green 
fluorescence signal from samples incubated with carazolol to the 
ones without carazolol. 
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SM1 The trials and errors of the expressions of β1AR/ β2AR proteins in TX-TL 
We made 4 different beta adrenergic receptor constructs to test the expression in TX-
TL: 
1. pSG72: Beta-1 adrenergic receptor (β1AR): P08588|ADRB1_HUMAN Beta-
1 adrenergic receptor. Codon optimized for expression in TX-TL. 
2. pSG73: β1ARts: 3ZPR. Thermostabilized turkey beta-1 adrenergic receptor. 
Codon optimized. 
3. pSG74: β2AR: P07550|ADRB2_HUMAN beta-2 adrenergic receptor. Codon 
optimized. 
4. pSG75: β2ART4L: 2RH1. Beta-2-adrenergic receptor/T4-lysozyme chimera. 
Codon optimized. 
All four genes were inserted into a backbone with OR2OR1-Pr as the promoter, 
UTR1 as the ribosome binding site, fused to a sfGFP gene, ColE1 as the replication 
origin, and Amp as the antibiotic selection marker (Figure 1B). 
We also made linear DNAs of each construct as shown in Supplementary Figure 
3 (except pSG72 where PCR failed). The pSG73 linear DNA map is used below for 
illustration purposes. The reason to use linear DNAs is that it is easier to make high 
concentration materials in a short time (3 hours using just PCR). The expression is 
almost as good as plasmids with protection protein gamS at present. 
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Supplementary Figure S3 Illustration diagram of the linear DNAs used for 
expression in TX-TL. They all share the same backbone with the same 
promoter, ribosome binding site, and terminator. They are all fused to a 
sfGFP-His tag. 
1 First expression test using plasmids 
For the first expression test, we put four plasmids pSG72-75 into TX-TL reactions 
with concentrations ranging from 4 nM to 7 nM with or without 40 nM MSP1D1-
His_DMPC (ND1) and MSP1E3D1-His_DMPG (ND3) and incubated the reaction 
mixes at 29°C for overnight. 
Because we have sfGFP fused to the target proteins, we used a plate reader to 
record real-time GFP fluorescence. However, the results were not promising. 
 
Supplementary Figure S4 Bar chart of the expression from constructs 
pSG72, 73, 74, and 75 in plasmids with or without nanodiscs, ND1 or 
ND3. The negative control was a TX-TL reaction without any DNA 
and showed the background fluorescence of the reaction mix. The Y 
axis was GFP relative fluorescence unit measured by a Biotek plate 
reader. 
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As we can see in Supplementary Figure S4, there was no significant protein 
expression above the negative control. We suspected that the DNA concentrations 
were too low to generate enough GFP signal. We then took the whole reaction mix 
(1 µL) and ran a SDS-PAGE gel (then stained with Coomassie Blue); we also used 
the same whole reaction mix (3 µL) and ran a western blot (Supplementary Figure 
S5). As we can see in the top panel, there were significant amounts of MSPs from 
the two different nanodiscs that we used in the experiment. But we did not see any 
other protein bands that were not in the negative control. On the western blot, we saw 
very strong bands from nanodisc MSP1E3D1, but not so much from nanodisc 
MSP1D1. And, consistent with the plate reader results, we did not see any of the 
target protein bands on the western blot. 
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Supplementary Figure S5 Top: SDS-PAGE gel results of the 
TX-TL reaction samples. Middle: Western blot results of the 
same gel. Bottom: A table describing the samples in each lane. 
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2 Second test with linear DNAs and pSG72 plasmid 
We thought that in the previous trial we did not have high enough of the plasmid 
concentrations to get strong fluorescence signal from TX-TL reactions. So, we 
decided to generate more materials by PCRing off those plasmids to get linear DNAs 
of them. All PCR reactions worked except for pSG72. So, we ended up using pSG72 
plasmid and pSG73-75 linear DNAs in this test. The pSG72 plasmid has a 
concentration range of 5 nM, 10 nM, and 15 nM and the pSG73-75 linear DNAs have 
a concentration range of 10 nM, 20 nM, and 40 nM. The fluorescence data of the 
expression of the aforementioned samples are plotted in Supplementary Figure S6. 
 
Supplementary Figure S6 Bar chart of the expression from 
constructs pSG72 in plasmids, 73, 74, and 75 in linear DNAs 
without nanodiscs. Three different DNA concentrations were 
used for each construct. The negative control was a TX-TL 
reaction without any DNA and showed the background 
fluorescence of the reaction mix. The Y axis was GFP relative 
fluorescence unit measured by a Biotek plate reader. 
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We can draw the following observations from this figure: 
1. The plasmid pSG72 still did not work although we increased the concentration 
to 15 nM. Something was wrong with all the plasmids that we used in this and the 
previous experiments. 
2. Fortunately, all the linear DNAs that we tried worked as expected. Both pSG74 
and 75 showed increased fluorescence when we increased the DNA concentrations. 
Only pSG73 reached maximum expression level at 10 nM. 
3. Usually linear DNA has lower expression level compared to the level of the 
plasmid DNA with the same concentration, meaning 10nM linear DNA should have 
less fluorescence compared to 10 nM plasmid DNA. We did not observe this in these 
experiments, which confirmed that there was something wrong with the plasmids. 
However, those linear DNAs based on these plasmids turned out to be good. The 
only difference here was that linear DNAs required gamS protection protein in TX-
TL; otherwise linear DNAs would be degraded much faster and produce much fewer 
protein. 
The fluorescence data were very encouraging. So, we took 1uL of the whole 
reaction mixes that showed significant fluorescence signals and ran both SDS-PAGE 
and western blots. To check whether the beta AR protein was in the precipitate or 
supernatant, we also spun down the whole reactions at 14,000 rpm for 10 min and 
took 1 uL of the supernatant and included them in the gels. 
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Supplementary Figure S7 Top: SDS-PAGE gel results of the 
TX-TL reaction samples. Middle: Western blot results of the 
same gel. Bottom: A table describing the samples in each lane. 
In Supplementary Figure S7, the top panel is the SDS-PAGE coomassie blue 
staining gel. We did not see any significant overexpression band on this gel, 
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suggesting that although we could detect fluorescence signal from the fusion protein, 
the amount was not enough to be seen on the less sensitive coomassie blue stain gel. 
The middle panel is the western blot of the same gel with anti-His antibody. We can 
make these following observations from the blot: 
1. Lanes 2-4 showed significant His tagged protein expression in the whole 
reaction mix, which was consistent with the fluorescence data. As the DNA 
concentration increased from 10 nM to 40 nM, we did not see significantly higher 
protein expression, suggesting it might have reached max level, which was also 
consistent with the plate reader fluorescence data. There were two significant bands 
in lanes 2-4. There was a strong band around 50 kD and β1ARts-sfGFP-His was 
around 65 kD. This had to be β1ARts-sfGFP-His as sfGFP-His was less than 30 kD, 
which could be the lower weak band. 
2. Lanes 5-7 showed significant His tagged protein expression in the whole 
reaction mix as well. As the DNA concentration increased from 10nM to 40nM, we 
saw significant higher protein expression from lanes 5 to 7, which was also consistent 
with the fluorescence data. However, these three lanes had more complicated band 
patterns: two smearing bands over 100 kD, one band between 50 kD and 75 kD and 
one intense band with a lighter band between 37 kD and 50 kD. β2AR-sfGFP-His 
should be around 76 kD. Nevertheless, we should have β2AR-sfGFP-His protein in 
the mix. 
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3. Lanes 8-10 showed similar results as the two we discussed above. β2ART4L-
sfGFP-His should be around 85 kD. We could see one intense band over 100 kD and 
another one between 50 kD and 75 kD. 
4. Lanes 12-14 are critical lanes as they are the supernatant samples of lanes 3, 6, 
and 9. As we can see very clearly in the blot, lanes 12-14 had almost no significant 
bands, suggesting the beta AR transmembrane proteins were mostly in precipitate, as 
we expected. 
3 Third test with linear DNA and nanodiscs 
Because of the encouraging results in the previous experiment, we decided to try 
nanodiscs again with 20 nM of the three linear DNAs pSG73-75. The results from 
the experiment are shown in Supplementary Figure S8. 
 
Supplementary Figure S8 Bar chart of the expression from 
constructs pSG73, 74 and 75 in linear DNAs with or without 40 
nM nanodiscs ND1 or ND3. The linear DNA concentration used 
for all three was 20 nM. 
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As we expected, all the linear DNAs showed strong expression just like the 
previous experiment. This time, we had nanodiscs as well in the reaction mix, and 
having nanodiscs in the reaction significantly increased the fluorescence signal. This 
was very encouraging because if the membrane protein precipitated, it might pull 
down the sfGFP fused to it as well, which would result in lower fluorescence signal. 
If nanodiscs could solubilize the membrane protein-sfGFP fusion, we should get 
higher fluorescence, as most proteins were now in the supernatant. 
To further test our hypothesis, we spun down all of the whole reaction mixes and 
took 1uL of each supernatant and ran both SDS-PAGE gels and western blots. In 
Supplementary Figure S9, the top panel is the western blot with anti-His antibody. 
Because the nanodiscs that we used have His tagged MSPs, we need to compare lanes 
3-11 to lanes 13 and 14, which did not have DNA but nanodiscs only. Lanes 3, 6, and 
9 had no significant bands in them, which was consistent with previous western blot 
results, suggesting that membrane protein would precipitate out when no detergent 
or nanodisc was present. Only when we added nanodiscs to the reaction mix could 
we see His tagged proteins (other than MSP) in the supernatant. All the non-MSP 
bands were labeled with red boxes in lane 4, 5, 7, 8, and 10. And when comparing 
these red boxes to those proteins in the second test, we can tell that these supernatant 
proteins were the same proteins from the whole reaction mix (same molecular 
weight), meaning that nanodiscs did help solubilize those membrane proteins. To 
further confirm those were the proteins of interest, we ran an exactly identical gel and 
performed the western blot with anti-GFP antibody. Results are shown in the middle 
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panel of Supplementary Figure S9. As we expected, the western blot results of the 
anti-GFP aligned well with the ones of the anti-His, suggesting that the bands marked 
with red boxes were our target proteins. As a comparison, the MSP (with His tag) 
bands only showed up in anti-His blot but not anti-GFP blot. 
These are very encouraging results. We demonstrate that with the addition of 
nanodiscs, we can prevent TX-TL made membrane proteins from precipitating, and 
thus solubilize the membrane proteins in the supernatant. With the anti-GFP western 
blot, we show that those higher molecular weight bands can be the suspected 
dimers/oligomers of our target proteins. 
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Supplementary Figure S9 Top: Western blot results of the TX-
TL reaction samples with anti-His antibodies. Middle: Western 
blot results of the same gel with anti-GFP antibodies. Bottom: A 
table describing the samples in each lane. 
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4 A control experiment to verify the existence of dimers/oligomers 
As we mentioned in the previous section, combining anti-His and anti-GFP 
western blots, we were confident that we observed not only GPCR-sfGFP monomers 
on the blots, but also their dimers/oligomers. All the gels were run without any 
reducing agents, thus in nondenaturing (native) conditions. To further verify the 
above assumption, we need to run a denaturing gel and western blot with reducing 
agents to see whether those higher molecular weight bands would disappear. If they 
would disappear in denaturing conditions, we would be certain that those bands were 
dimers/oligomers of GPCR-sfGFP. 
TX-TL reactions (with nanodiscs), gels and western blots were performed using 
the same protocol, except when gel samples were prepared using supernatants from 
the TX-TL reactions, reducing agents and 10 min heating at 70°C were performed to 
create denatured proteins. Results are shown in Supplementary Figure S10. As we 
can see in the figure, there was possible existence of β2ART4L-sfGFP dimers 
between 100kD and 150kD at nondenaturing conditions. But the band disappeared 
in the lane with reducing agents, which can break the disulfide bonds that connect 
two monomers to be dimers. These results suggest that we have both monomers and 
dimers of the GPCR-sfGFP proteins. 
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Supplementary Figure S10 Western blot results of β2ART4L-sfGFP-
His proteins with and without reducing agents. 
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SM2 Expressing a chimera potassium channel membrane protein KcsA-Kv1.3 
in TX-TL 
The first membrane protein that we tried to express and solubilize in TX-TL was a 
potassium channel membrane protein KcsA-Kv1.3, which was of interest to our 
collaborators at Amgen. 
KcsA is a prokaryotic potassium channel from Streptomyces lividans [95] and 
Kv1.3 is a human voltage-gated potassium channel [96]. It has been shown that there 
is a remarkable structural conservation between the pore structures of the prokaryotic 
KcsA and eukaryotic Kv channels [97]. The chimeric KcsA-Kv1.3 is created by 
swapping subregions of the M1-M2 linker of KcsA with those of the S5-S6 linker of 
the Kv1.3. Because of that, not only is the chimeric potassium channel able to bind 
to specific toxins with high affinity, but it can also be expressed in E. coli [98]. 
As the TX-TL extract is based on E. coli, it would be reasonable to think that we 
might be able to express KcsA-Kv1.3 in TX-TL and solubilize it with membrane-
like materials. However, Kv1.3 (we will use Kv1.3 instead of KcsA-Kv1.3 in the 
following paragraphs for simplicity) needs to form tetramers in order to be  
functional [99], which can be very challenging as there are few chaperone proteins 
in TX-TL to help the folding and formation of the tetramers. 
To start, we tested a construct pCon-His6-Kv1.3, in which the N-terminal His 
tagged Kv1.3 is constitutively expressed in TX-TL. We prepared six samples: 1) a 
negative control with only TX-TL reaction mix; 2) a positive control consisting of 
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160 ng purified Kv1.3 proteins in tetramer form; 3) the pellet from a reaction 
containing 15 nM Kv1.3 DNA (spun for 10 min at 14000 rpm to separate the pellet 
from the supernatant); 4) the supernatant from (3); 5) the sample from a TX-TL 
reaction containing 40 nM MSP1D1-His_DMPC (ND1); 6) the sample from a TX-
TL reaction containing 40 nM MSP1E3D1-His_DMPG (ND3). 
After incubating the TX-TL reactions at 29°C for at least 8 hours (except for the 
negative control), we took 1 µL out from each reaction mix and ran both SDS-PAGE 
gels and western blots. The results are shown in Supplementary Figure S10. 
 
 
Supplementary Figure S11 Top left: SDS-PAGE gel results of 
the TX-TL reaction samples. Top right: Western blot results of 
the same gel. Bottom: A table describing the samples in each 
lane. 
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As we can see in the top left panel, the SDS-PAGE coomassie blue stain gel 
showed that 1) there was an abundance of proteins in the extract (lane 2); 2) purified 
Kv1.3 protein samples contained mostly tetramers and some monomers (lane 3); 3) 
the pellet sample in lane 4 showed the possible existence of Kv1.3 monomers made 
in TX-TL, and so did lanes 6 and 7 (among all the other protein bands from the 
extract). After analyzing the top right panel, which was the western blot with anti-
His antibody, we confirmed the tetramers in the positive control (lane 3); in the same 
lane, we also saw some monomers and possible dimers among the smearing region. 
In lanes 4 and 5, we clearly observed that there was no Kv1.3 protein in the 
supernatant, but there were monomers and possibly dimers in the pellet. Most 
importantly, lane 6 and 7 showed that nanodiscs did not help the formation of Kv1.3 
tetramers in TX-TL, which meant that it was very unlikely to have Kv1.3 proteins 
inserting into nanodiscs and forming tetramers spontaneously. 
The construct we tested was pCon-His6-Kv1.3, which had the His tag at the N 
terminus. There have been some studies on the differential effect of a His tag at the 
N- and C-termini [100]. So, we decided to make and test a construct pCon-Kv1.3-
His6 (pSG69), which had the His tag at the C terminus. Additionally, we would like 
to monitor the production of Kv1.3 in TX-TL and a convenient way to achieve this 
is fusing a fluorescent protein to Kv1.3. It has also been shown that some fluorescent 
proteins are prone to forming low-affinity oligomers and this tendency is boosted 
when fluorescent proteins are confined to membranes or when fused to naturally 
oligomeric proteins [101]. We thought this characteristic of fluorescent proteins 
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might help Kv1.3 monomers form tetramers when they were fused to fluorescent 
proteins in vitro. So, we designed and made a Kv1.3-sfGFP fusion construct pCon-
Kv1.3-sfGFP-His6 (pSG66). 
We tested the expression of both constructs in TX-TL with and without 
detergents. However, as the western blot shown in Supplementary Figure S11, we 
did not observe any hints of the formation of Kv1.3 tetramers, in neither C-terminal 
nor fusion constructs, after comparing lane 1 to lane 3 and lane 2 to lane 4. Not only 
did we test detergent Brij35 with pSG66 and pSG69, but we also tried these 
constructs with detergents DM (2X CMC), LMPG (5X CMC), 
CHAPS/DMPC&DMPG bicelles, and 12 nM and 40 nM nanodisc MSP1E3D1-His-
DMPG, and none of them helped the formation of Kv1.3 tetramers (data not shown). 
 
After failing to generate Kv1.3 tetramers spontaneously in TX-TL with 
membrane-like materials, we changed our strategy to generate Kv1.3 monomers in 
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Supplementary Figure S12 The western blot 
results of pSG66 and pSG69 expressed in TX-TL 
with or without detergent Brij35. Lane 1 and 3 are 
pSG66 (Kv1.3-sfGFP fusion) samples; lane 1 has 
no detergent added and lane 3 has 10X CMC Brij35 
added. Lane 2 and 4 are pSG69 (Kv1.3-His6) 
samples; lane 2 has no detergent and lane 4 has 10X 
CMC Brij35. A ladder is added in lane 5. The blot 
was incubated with anti-His antibody.  
Chapter 3 
 
 
 
112 
TX-TL and hoped to refold the misfolded Kv1.3 into correctly folded Kv1.3 
tetramers. 
Briefly, the refolding protocol is listed as below: 
1. Set up 1 mL TX-TL reactions with corresponding DNA constructs 
(original construct, pSG66 or pSG69). After incubating the reactions at 
29°C for at least 8 hours, spin down the reactions at 14,000 rpm for 10 
min to harvest the pellets. 
2. Incubate the TX-TL pellet with 200 µL 8M urea solution for 2 hours to 
unfold Kv1.3 proteins, and then purify the His tagged Kv1.3 proteins 
using HisPur Ni-NTA spin purification kit (including Ni-NTA resin on 
columns). 
3. After incubating protein samples with the Ni-NTA resin for 2 hours, 
start refolding on columns with a pump circulating refolding buffer 
(20mM Tris pH7.5, 100 mM NaCl, 20 mM DM, 5 mM DMPG) and 
leave overnight. Then elute proteins with 500mM imidazole with 
refolding buffer. 
After elution, refolded Kv1.3 proteins were used to run on SDS-PAGE and 
western blot. Supplementary Figure S12 shows the western blot results of the 
refolded proteins Kv1.3-His6 and Kv1.3-sfGFP-His6. As we can see, the middle lane 
shows that after refolding there were very likely traces of Kv1.3 monomers, dimers, 
and tetramers on the blot, though the amount of tetramers was quite limited. In the 
Chapter 3 
 
 
 
113 
right lane, we can see a much higher yield of Kv1.3-sfGFP-His6 proteins, which is 
consistent with our previous observation in Figure S11. We could have traceable 
amounts of both Kv1.3-sfGFP dimers and tetramers after the refolding process, and 
we also saw an intense band under the monomer band, which could be truncated 
sfGFP-His6. 
 
The western blotting results were promising but not conclusive. If we have 
correctly folded tetramers, we could potentially verify their activity by testing their 
binding to the blocker ShK peptides. A 35-amino acid-residue polypeptide ShK from 
the sea anemone Stichodactyla helianthus has been shown to be a potent blocker for 
the Kv1.3 channel [102]. To perform the binding assay, we used a surface plasmon 
resonance (SPR)-based optical biosensor. We tethered ShK peptides to a CM5 chip 
and tested the binding of different Kv1.3 proteins by flowing samples through the 
individual channel on the chip (Supplementary Figure S13A). The results are shown 
in Supplementary Figure S13B. As we can see, unfolded Kv1.3 proteins were poorly 
bound to the ShK-tethered surface; in contrast, the refolded Kv1.3 proteins showed 
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Supplementary Figure S13 The western 
blot results of refolded Kv1.3-His6 and 
Kv1.3-sfGFP-His6 proteins. A ladder is 
added in the left lane. The middle lane is the 
refolded Kv1.3-His6. The right lane is the 
refolded Kv1.3-sfGFP-His6. The blot was 
incubated with anti-His antibody.  
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significant binding response to the surface. Moreover, the refold Kv1.3 incubated 
with free ShK peptides showed significantly lower binding to the surface, indicating 
the binding between Kv1.3 and ShK-CM5 was specific. 
 
Supplementary Figure S14 A: An illustrative diagram 
describes a binding assay designed for Kv1.3 proteins. The SPR 
chip was CM5 and was coated with ShK peptides. Active Kv1.3 
proteins flowed through the chip can bind to the ShK peptides 
and result in an increase of the SPR response unit. B: A bar chart 
of the SPR binding assay results. The Y axis is the SPR response 
unit measured from a Biocore 2000. Unfolded Kv1.3 is the 
protein sample incubated in 8M urea solution for 2 hours; 
refolded Kv1.3 + ShK is the refolded Kv1.3 protein samples 
incubated with ShK peptides for 1 hour.  
In conclusion, we failed to express active Kv1.3 membrane proteins in TX-TL 
with membrane-like materials, including nanodiscs; however, with an additional 
refolding process post-TX-TL, we were able to produce active Kv1.3 tetramers 
showing specific binding to their blocker, significantly advancing our understanding 
of the potential of the TX-TL platform.
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Appendix I 
Quantification of Terminator Strengths Using Linear DNAs in TX-TL 
An important part of the DNA constructs, but sometimes overlooked, is the 
transcription terminator, which is a section of nucleic acid sequence that marks the 
end of a gene or operon in genomic DNA during transcription [103, 104]. Intrinsic 
transcription terminators of prokaryotes are distinguished by a common RNA motif 
– a stem loop structure [105]. A recent study on the transcription terminators 
characterizes 582 natural and synthetic terminators and their respective termination 
strength [106]. That study provides great insights into the understanding of 
terminators and useful guidance on choosing terminators when building synthetic 
biocircuits. In that study, terminator strength was determined from a simple assay that 
compares the expression of two fluorescent reporters, one placed before and one after 
the terminator, and the assay was done using plasmids in cells. Because we often use 
linear DNAs instead of plasmids when we prototype biocircuits in the cell-free 
transcription-translation system (TX-TL), we would like to find out whether the 
terminators would perform any differently if this were done using linear DNAs in the 
(TX-TL).  
To that end, we chose a standard terminator (T500) that we used in our lab and 
four of the strongest terminators (T13-16) from [106]. We also included a T-neg, 
which is a short sequence with no significant secondary structure, as a negative 
control. We chose to use CFP as the main reporter fluorescent protein and GFP as the 
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leaky reporter. We started with DNA1, which has a pLac promoter activated by IPTG 
and a strong ribosome binding site (RBS) UTR1. All the DNA1s have CFP gene and 
one of the six terminators (Figure 1). We also built DNA2, consisting of only a RBS, 
a gene and a terminator; as a result of no promoter, DNA2 itself cannot be transcribed. 
We then used the Gibson assembly to stitch DNA1 with DNA2 and generated six 
different DNA1-2s. For DNA1s and DNA1-2s, they can be activated with the 
addition of IPTG and produce CFP regardless of what terminators are used. The CFP 
signal should also be the same among all the DNAs when activated with the same 
concentration of IPTG as they all share the same promoter, RBS and gene. 
 
Figure 1 Illustration diagrams of constructs used for the 
terminator strength assay. Upper panel: DNA1: linear DNAs 
pLac-UTR1-CFP with the selected terminators T*, respectively. 
DNA2: a piece of linear DNA consisting of only RBS-B0034, 
reporter GFP and terminator T500 but no promoter. DNA1-2: 
linear DNAs pLac-UTR1-CFP-T*-B0034-GFP-T500, made by 
ligating DNA1 and DNA2 together using Gibson assembly. 
Bottom panel: the terminator strength assay was performed with 
six different DNA1, one DNA2, and six different DNA1-2, and 
each had three repeats. 
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DNA1-2s can also produce GFP fluorescence, which is an indicator of how strong 
the terminator T* is. The stronger the terminator T* is, the lower the GFP 
fluorescence will be generated (less leaky). We set up 14 TX-TL reactions (times 3 
repeats) with six different DNA1s, six different DNA1-2s, a positive control, and a 
negative control (DNA2). After 12 hours, we measured the CFP and GFP 
fluorescences of all the samples and the normalized results were plotted in Figure 2. 
As we can see in Figure 2A, DNA2, the negative control, had no expression as 
expected. DNA1s had significant CFP signals but little to no GFP signals, also as 
expected. DNA1-2s showed varied results, depending on which terminators were 
used. The T-neg-B, which has no terminator between, showed the highest leaky GFP 
expression. And the T13-B with the strongest terminator T13 showed the lowest GFP 
signal.  
With these encouraging results, we quantify the terminator strength using the 
following equation adapted from the one in [106]: 
𝑇𝑒𝑟𝑚𝑖𝑛𝑎𝑡𝑜𝑟	𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ = 𝐶𝐹𝑃À𝐺𝐹𝑃À 𝐶𝐹𝑃t𝐺𝐹𝑃t {, 
in which CFPB and GFPB are the CFP and GFP fluorescent signals from DNA1-2s 
(T500-B, T13-16-B, T-neg-B in Figure 2), and CFP0 and GFP0 are the fluorescent 
signals from DNA1s (T500, T13-T16, T-neg in Figure 2). The terminator strength of 
each terminator was then calculated and plotted in Figure 2B. Comparing the results 
to the ones in [106] plotted in Figure 2C, they were consistent, in which T13 was the 
strongest and T14-T16 were similar but stronger than T500. 
Appendix 
 
 
 
118 
To summarize, we characterized and quantified the terminator strengths of the 
selected terminators using linear DNAs in TX-TL. We found that terminators in TX-
TL behaved at similar relative strengths to in vivo experiments, although much lower 
efficiency. We suspect that linear DNAs are more flexible and have less rigid 
secondary structures compared to their circular plasmid counterparts. This could 
affect the rigidity of the stem-loop structure of the terminators, resulting in leakier 
transcription. While we would like to note that with linear DNAs in TX-TL, one does 
not need terminators after the coding sequences as we usually have only one coding 
sequence on one piece of linear DNA and leaky transcription should not affect the 
outcomes at all. But this study provides an opportunity to examine the terminators in 
different media and different environments, reminding us of the differences that we 
need to take into account when translating results from one platform to the other. 
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Figure 2 The terminator strength assay data. A: Normalized 
fluorescence data plotted in a bar chart. For every sample, two 
fluorescence measurements were taken (CFP: excitation 430 nm 
and emission 470 nm; GFP: excitation 485 nm and emission 525 
nm) after 12-hour incubation of the TX-TL reactions. For clear 
comparisons, we normalized the CFP fluorescences from the 
samples with the same terminator (T500 and T500-B and etc.) 
to be equal while keeping CFP/GFP fluorescence ratio constant. 
The pos. control is a sample with pCon-GFP DNA as a positive 
control. Sample pB0034 is the DNA2. Samples T500, T13-T16 
and T-neg are DNA1s, and T500-B, T13-16-B, and T-neg-B are 
DNA1-2s. B: A bar chart showing the normalized terminator 
strengths calculated from the data in A using the terminator 
strength equation. C: A bar chart showing the terminator 
strength data of the same terminators from [106]. 
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CONCLUSION AND FUTURE DIRECTIONS 
In this thesis, we investigate several biological circuits in a cell-free transcription-
translation system (TX-TL). We demonstrated three distinct aspects of biological 
circuits: circuit dynamics (Chapter 1), phosphorylation (Chapter 2), and membrane 
proteins (Chapter 3). We successfully prototype a feedforward loop circuit using 
mathematical modeling in the TX-TL system and further implement it in cells. We 
also prototype a phosphorylation-based insulator circuit in the TX-TL and perform 
system identification of a mathematical model for the circuit by leveraging the 
advantages of the cell-free system. We further demonstrate that the TX-TL system 
could be used to prototype circuits involving membrane proteins by expressing 
biologically active membrane proteins in the system with extra engineering. Overall, 
these results bring us one step closer to the goals of utilizing biological circuits to 
control cells. 
Prototyping biocircuits in the TX-TL system is the first step towards engineering 
biological systems in a fashion that resembles electrical engineering. A cellphone that 
is capable of doing many things is made of thousands of modular electronic 
components. If we were to one day build a cell with a specific function like 
assembling a cellphone, we need to gain much more understanding of the parts 
underlying the cell. If we were to one day develop novel, functional, and modular 
biological circuits in the same manner as building electronic circuits on a breadboard, 
we ought to prototype parts on a “biomolecular breadboard”, such as the TX-TL 
system. 
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In the TX-TL system, one can skip the cell growth step, and go straight into parts 
characterization. It has been shown (in this thesis and previous studies) that the TX-
TL is a helpful platform for prototyping because of its simplicity, freedom, and 
convenience. We have described in the thesis some of the limitations of the current 
TX-TL system: limited resources, batch-to-batch variations, and vitro-to-vivo 
inconsistency. To make the TX-TL more instructive, we should supply the TX-TL 
reactions with continuous fresh resources. We should standardize the characterization 
process of the parts underlying biological circuits. We should develop a reference or 
an algorithm to offset the batch-to-batch variations by normalizing all major 
parameters towards the same standard. We should account for the differences 
between the cell-free system and cell-based system to resolve the inconsistency 
between them with a sufficient mathematical model. 
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